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Abstract 
 
The dramatic growth in the aquaculture sector has emphasized the importance of fish 
disease control. Due to the risk of development and transfer of antibiotic resistance 
alternative disease control measures to use of antibiotics must be implemented. The use 
of probiotics, which are live microorganisms that confer a health benefit to the host, may 
be an alternative to antibiotics in some situations. Mostly, potential probiotic bacteria have 
been selected due to their ability to antagonise pathogenic microorganisms, however, the 
mechanism by which they confer a health benefit are not known. Most studies rely on in 
vitro data and in vivo data, such as challenge trials, are scarce. 
 
Several marine bacteria are capable of inhibiting other bacteria and some marine bacteria 
appear promising as probiotics in aquaculture. Roseobacter strain 27-4 a member of the 
Roseobacter clade, is a probiotic candidate. Roseobacter 27-4 was selected due to its 
strong anti Vibrio activity and it is capable of reducing mortality in turbot larvae infected 
with Vibrio anguillarum. It is hypothesized that the Roseobacter antibacterial activity, is an 
important mechanism underlying its probiotic effect. 
 
The purpose of this thesis has been to investigate factors influencing Roseobacter 27-4 
production of antibacterial compounds and to elucidate the structure, regulation and 
biosynthesis of the active compound. 
 
The antibacterial activity of Roseobacter 27-4 was due to production of a sulphur 
containing compound, tropodithietic acid (TDA). TDA was also found in supernatants from 
Silicibacter TM1040, also a member of the Roseobacter clade. V. anguillarum did not 
become resistant to TDA even when continuously exposed to sublethal doses. Hence, 
production of TDA may have a persistent effect against this fish pathogen. 
 
Static growth conditions enhanced TDA production and favoured a thick biofilm of rosette 
shaped aggregated for both Roseobacter 27-4 and Silicibacter TM1040. It is suggested 
that rosette/biofilm formation and production of TDA are connected phenotypes in both 
bacteria. The mechanisms or reason behind Roseobacter rosette formation is not known, 
but it is suggested that the rosette formation, may be a way for the bacteria to avoid 
grazing by protozoan. This defence can be enhanced by biofilm formation and production 
of TDA, as TDA also act as an antiprotozoan compound. 
 
In this thesis it is hypothesised that colonization of surfaces can enhance the antibacterial 
effect of Roseobacter 27-4 and hence, create a stable long-term beneficial microbiota in 
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aquaculture environments. A novel way of quantifying both the probiotic and pathogenic 
bacteria during attachment is presented by using Real time PCR. Such a method will be 
useful in evaluating the effect of probiotic bacteria during colonization of surfaces. 
 
All bacterial strains tested were sensitive to TDA, but non-Roseobacter strains were in 
general more sensitive to TDA as compared to members of the Roseobacter clade. 
Hence, production of TDA may give Roseobacter a selective advantage during interaction 
with other bacteria. Random transposon genomic mutagenesis was use to suggest a 
biosynthesis pathway for TDA. Several genes believed to be involved in the final formation 
of TDA are located on a plasmid, which may explain the loss of TDA production in 
spontaneously TDA negative mutants, as loss of the plasmid. TDA is a sulphur containing 
compound and some roseobacters metabolise the algal sulphur compound 
dimethylsulfoniopropionate (DMSP) and this metabolism has been linked to the global 
climate. The thesis hypothesised that TDA could be produced with DMSP as sulphur 
substrate but could not confirm this. Cysteine and sulphate was suitable substrates for 
TDA synthesis, whereas methonine could not be metabolised to TDA. 
 
Several Roseobacter strains isolated from algae produced antibacterial compounds and 
some strains also formed rosette shaped aggregates, which improved their attachment 
capability. In the present thesis it is suggested that members of the Roseobacter clade 
may become dominant among algal associated bacterial, due to their production of 
antibacterial compound and high attachment capability.  
 
The thesis concludes that the production of TDA by members of the Roseobacter clade is 
highly influenced by growth conditions. Enhanced production of TDA might improve the 
health of the aquatic organisms in aquaculture as these are unaffected by TDA whereas 
fish pathogenic bacteria are sensitive. Hence to facilitate and optimize the use of 
Roseobacter strains as probiotic bacteria, new ways of adding the bacteria which results in 
an enhanced TDA production will be an advantage. Further studies on the marine ecology 
of Roseobacter in relation to production of antibacterial compounds, will be of great 
interest due to their abundance in the oceanic environment. 
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Resume 
 
Øget fokus på bekæmpelse af fiskesygdomme vil være nødvendigt, hvis den dramatiske 
stigning i akvakultur skal forsætte. Bakterielle sygdomme i akvakultur kan behandles med 
antibiotika, men grundet angst for udvikling og overførsel af resistens vil alternative 
metoder med fordel kunne implementeres. Brug af levende mikroorganismer, kaldet 
probiotika, som forbedre helbredet hos akvatiske organismer kan være et alternativ til 
antibiotika i nogle situationer. De fleste potentielle probiotiske bakterier er udvalgt baseret 
på deres evner til at hæmme fiskepatogene bakterier men det er uvist hvorfor stammerne 
har en helbredsforbedrende virkning på akvatiske organismer. De fleste undersøgelser er 
baseret på in vitro data og in vivo data er ofte ikke rapporteret.   
 
Adskillige marine bakterier har evne til at hæmme andre bakterier og nogle af disse er 
ligeledes lovende probiotiske stammer til akvakultur. Roseobacter 27-4 som tilhører 
Roseobacter gruppen, er en af de lovende probiotiske kandidater. Roseobacter 27-4 blev 
udvalgt som probiotisk kandidat grundet dens evne til at hæmme fiskepatogene bakterier, 
samt at det er vist at den kan reducere dødeligheden hos pighvar larver inficeret med 
Vibrio anguillarum. Det er foreslået at den probiotiske effekt af Roseobacter 27-4s er 
forbundet med dens evne til at hæmme andre bakterier.  
 
Formålet med nærværende opgave er at undersøge faktorer der influerer Roseobacter 27-
4s produktion af antibakterielle stoffer og beskrive strukturen, reguleringen samt 
biosynthesen af de aktive antibakterielle stoffer. 
 
Den antibakterielle aktivitet skyldes produktionen af et antibakterielt stof, der er 
identificeret som tropodithietic cid (TDA). TDA er ligeledes fundet i supernatanter fra 
Silicibacter TM1040, som også tilhører Roseobacter gruppen. Langvarig vækst af V. 
anguillarum i ikke dræbende koncentrationen af TDA resulterede ikke i resistens udvikling. 
Derfor kan TDA måske have en vedvarende effekt mod fiskepatogene bakterier. 
 
I kulturer af Roseobacter 27-4 og Silicibacter TM1040 øges produktionen af TDA under 
statiske vækstbetingelser. Under disse vækstforhold dannes også en tynd biofilm af 
rosetteformede aggregater. Der synes at være en forbindelse mellem rosette/biofilm 
dannelsen og produktionen af TDA i begge bakterier. Mekanismerne bag og grunden til 
dannelsen af disse rosetter er ukendt men rosetterne er foreslået at medvirke som en 
forsvarsmekanisme mod græsning af protozoer. Denne forsvarsmekanisme kan blive 
forstærket af biofilmdannelse og produktion af TDA, da TDA også har en hæmmende 
virkning på protozoer. 
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Overfladekolonisering med probiotiske bakterier som Roseobacter 27-4 kan måske skabe 
en fordelagtig og stabil mikroflora i akvakulturmiljøet og dermed mindske udbrud af 
bakterielle sygdomme. Til evaluering af en sådan kolonisering er en Real time PCR 
metode udviklet, således det er muligt at kvantificere både probiotiske og fiskepatogene 
bakterier.  
 
Bakterier der ikke tilhører Roseobacter gruppen er generelt mere følsomme overfor TDA 
sammenlignet med bakterier som tilhører Roseobacter gruppen. Produktion af TDA kan 
derfor give Roseobacter en selektiv fordel under interaktion med andre bakterier. 
Dannelse af TDA er undersøgt i nærværende opgave vha. transposon mutagenese. 
Denne analyse viser, at centrale gener i dannelsen af TDA er placeret på et plasmid, og at 
tab af dette plasmid derfor kan forklare hvorfor spontane TDA negative mutanter blev 
fundet. Strukturen af TDA indeholder to svovlatomer hvilket er interessant da nogle 
Roseobacter nedbryder det svovlholdige stof dimethylsulfoniopropionate (DMSP). Denne 
nedbrydning kan påvirke det globale klima og det er blevet foreslået at TDA kan 
produceres af Roseobacter med DMSP som svovlsubstrat. Denne hypotese blev dog ikke 
bevis i nærværende opgave. TDA kan produceres med cysteine og sulfate som svovlkilde, 
men ikke med methonine. 
  
Adskillige Roseobacter stammer isoleret fra alger producerer antibakterielle stoffer og 
nogle af disse stammer viste sig ligeledes at have gode fasthæftelsesevner. Disse 
fænotyper kan være vigtige for Roseobacter bakterier i at opnå dominans blandt 
algeassocierede bakterier. 
 
Det kan konkluderes at produktionen af TDA produceret af medlemmer af Roseobacter 
gruppen er meget påvirket at de fysiske vækstforhold. Forøget produktion af TDA kan 
måske forbedre overlevelsen af akvatiske organismer i akvakultur, da disse ikke er 
følsomme overfor TDA hvorimod fiskepatogene bakterier er meget følsomme. Skal brugen 
af Roseobacter stammer optimeres, vil det være en fordel at tilføre disse på en måde så 
TDA produktionen øges. Yderligere undersøgelser af Roseobacter gruppen i forhold til 
produktion af antibakterielle stoffer vil være af stor interesse, da Roseobacter er 
dominerende i mange forskellige akvatiske miljøer. 
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1 Introduction 
 
Aquaculture is farming of aquatic organisms, including fish, molluscs, crustaceans and 
aquatic plants, and is one of the fastest growing food-producing sectors in the world, with 
an annual growth rate of 8.9% from 1970 to 2000 (FAO 2003) (Figure 1). The annual 
increase has been 6.1% from 2000 to 2002 and the total world aquaculture production was 
in 2002 51.4 million tons by quantity and US$60.0 billon by value (FAO 2004). It is 
estimated that this increase will continue during the next decade (Figure 1), if the 
aquaculture sector overcomes several challenges (FAO 2004). The production of aquatic 
organisms is intensive and microbial diseases may spread rapidly within the production 
sites. Infectious diseases are currently the most devastating problem in shrimp culture and 
present ongoing threats to other aquaculture sectors.  
 
Figure 1: Production (in million tones of 
aquatic organisms) of captured or produced in 
aquaculture from 1950 until today. Estimates 
for the following decades are included (FAO 
2004) (Figure made by Lone Gram). 
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Fish diseases are caused by different agents e.g. virus or bacteria, and the focus of this 
thesis will be on bacterial agents. As for terrestrial animals, antibiotics have been and are 
currently being used for the treatment of bacterial diseases. This use of antibiotics is giving 
rise to concern, as use of antibiotic in animal production increase the selective pressure 
exerted on the microbial environment and encourages the natural emergence of bacterial 
resistance. Resistant fish pathogenic bacteria are a problem in the aquaculture sector 
(Karunasagar et al., 1994), and possible transfers of resistance genes to human 
pathogens give rise to additional concern. Several alternative strategies for the use of 
antibiotics have been proposed and in particular vaccines have already been applied very 
successfully in aquaculture. Norway increased fish production from approximately 50,000 
metric tons to 400,000 metric tons between 1987 and 1997 and decreased the use of 
antibiotic from 50 metric tons to about 750 kg (Verschuere et al., 2000b). However 
vaccination cannot be used in all cases. During hatching of fish and in the larvae stage the 
1 
size of the fish and slow development of the immune system makes it difficult to use 
vaccines. Crustaceans and molluscs lack acquired immunity and conventional vaccination 
cannot be used. For this reason new alternative strategies must be implemented and the 
use of probiotic organisms in aquaculture is promising. Probiotics are live microorganisms, 
which confer a health benefit for the host when administrated in adequate amounts 
(FAO/WHO 2001). 
 
Many microbial strains have been tested as probiotic organisms and several bacterial 
strains have a disease reducing effect. This thesis will give an overview of probiotic 
bacteria applied within aquaculture. The focus will be on Roseobacter strain 27-41, which 
is one of the promising probiotic candidates. Roseobacter 27-4 was originally isolated from 
a turbot rearing facility due to its strong anti-Vibrio activity (Hjelm et al., 2004a). This strain 
and related strains appeared to constitute a relatively stable community within the rearing 
facility (Hjelm et al., 2004b) and were especially associated with the walls of the rearing 
tanks. To facilitate and optimize the use of probiotic bacteria such as Roseobacter 27-4 
within aquaculture productions, it is necessary to understand their ecology. Since 
production of antibacterial compounds is often believed to be the mode of action of 
probiotic bacteria, it is important to understand how environmental factors affect the 
production of these.  
  
Probiotics are generally administrated as live microbial feed supplements. Since 
Roseobacter 27-4 is associated with the tank wall of the rearing tanks, we suggest that this 
probiotic bacterium can be administrated by colonizing the surfaces of the rearing tanks. A 
well-established biofilm of probiotic bacteria might prevent the proliferation of fish 
pathogenic bacteria. However, if such a practice is to be applied, methods must be 
developed to quantify both the probiotic and pathogenic bacteria during biofilm formation 
to study the interaction. Hence, development of new ways to specifically quantify bacteria 
attached to surfaces will be investigated in this thesis. 
 
It is unlikely that the bacteria produce antibacterial compound for protection of fish larvae. 
This behaviour must be important for the bacterium in its natural habitat. Members of the 
so-called Roseobacters clade are very common in marine environments and represent 20 
– 30 % of the bacterial communities in the upper mixed layer of the ocean. This group is 
often most abundant in bacterial communities associated with marine algae and in coastal 
biofilms (Buchan et al., 2005). Members of the Roseobacter clade can affect the growth of 
                                            
1 Roseobacter 27-4 is based on 16S rDNA closely related to Roseobacter gallaeciensis, which recently was 
reclassified as Phaeobacter gallaeciensis (Martens et al., 2006b). Since two published papers uses 
Roseobacter 27-4 I have chosen to retain this in this thesis  
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the algae (Alavi et al., 2001) and play an important role in the global marine carbon and 
sulphur cycle (Wagner-Döbler and Biebl 2006). The fact that this group of bacteria is most 
abundant in algae communities, gives them a central role in the marine environment.  
 
The purpose of this thesis has been to investigate factors influencing Roseobacter 27-4 
production of antibacterial compounds and to elucidate the structure, regulation and 
biosynthesis of the active compound. 
 
We hypothesize that production of antibacterial compounds is an important phenotype for 
probiotic bacteria e.g. Roseobacter 27-4 and that this phenotype is correlated to the 
growth conditions of the bacteria. We also believe that if production of antibacterial 
compounds is a general phenotype among bacteria belonging to the Roseobacter clade it 
will influence their dominance within the marine environment. Hence, this thesis addresses 
the occurrence of antibacterial activity among marine Roseobacter strains.  
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2 Probiotic in aquaculture 
 
2.1 Definition of probiotic microorganisms 
 
The definition of the term probiotics has changed over time. The expression probiotic 
stems from combining the Latin word pro (for) with the Greek word bios (for life) (Zivkovic 
1999). The term probiotics denotes bacteria that promote the health of other organisms. 
Lilly and Stillwell (1965) defined probiotic as “Substances produced by microorganisms 
which promote the growth of other microorganisms” but this has changed over the years 
as new understanding has emerged. In general, the interest has centred on terrestrial 
organisms, and the term probiotic inevitably referred to Gram-positive bacteria associated 
with the genus Lactobacillus. The use of Gram-positive bacteria in human feed gave rise 
to a definition by Fuller (1989), “a live microbial feed supplement which beneficially affects 
the host animal by improving its intestinal balance”. However, this definition is not 
applicable in aquaculture. The fact that the probiotic has been supplied as feed makes 
sense in human or other terrestrial animals, because the importance of the gastrointestinal 
tract is clearly recognized as onset of pathogen proliferation and invasion site. However, 
this is not the case for fish. Host and microorganisms are submerged in water and 
therefore areas such as skin and gills are important as site of proliferation and invasion 
site for fish pathogenic bacteria. Furthermore a review by Cahill (1990) reported that the 
bacterial present in the aquatic environment influence the composition of the gut 
microbiota and vice versa. Therefore, Verschurer et al., (2000b) claimed that in 
aquaculture systems the immediate ambient environment has a much larger influence on 
the health status than in terrestrial animals or humans. Probiotic in aquaculture may be 
more parallel to biocontrol, which is used for microbial cultures that prevent plant diseases. 
Based on the above the term probiotic will in this thesis be defined as “Probiotics are live 
microorganisms, which when administrated in adequate amounts, confer a health benefit 
for the host” (FAO/WHO 2001). This definition covers the supplement of a probiotic 
organism to the host environment or the feed.  
  
The question is how to define beneficial effect, or how to determinate if a microorganism is 
successful as being a probiotic microorganism. Live microbial cultures may be 
administrated in aquaculture with different purposes e.g. disease prevention / 
minimization, as feed or as water quality improvement. All of these will directly or indirectly 
benefit the health and/or survival of the aquatic organism. For this reason, Gram and 
Ringø (2005) proposed that the effect of a probiotic could be measured by its ability to 
decrease frequency of disease and/or increase survival from lethal diseases.  
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Even though more than two thousand publications deal with the concept of using probiotic 
to benefit health of human and animals, the concept is still questioned (Berg 1998; Atlas 
1999; Gomez-Gil et al., 2000; Gram and Ringø 2005).  
 
Gomez-Gil et al., (2000) reviewed the use of probiotic bacteria in fish larvae cultures. They 
concluded that the available information is inconclusive, since few experiments with 
sufficient robust design have been conducted to permit critical evaluation. Gram and Ringø 
(2005) concluded that there is a general lack of in vivo studies. There is also a need for 
specific cause and effect relationships that can be substantiated scientifically (Atlas 1999). 
To understand the areas in which the probiotic concept is viable, we must understand the 
mechanisms by which such treatment works. This will require detailed knowledge of (Gram 
and Ringø 2005); 
  
• The pathogen, its virulence, its proliferation and invasion sites 
• The host, its immune defence, and its natural microflora  
• The surrounding environment, including nutrients, microorganisms etc. 
• The probiont, its functional features, its mechanisms of action, and its effect on the 
general microflora etc. 
 
Today no studies dealing with probiotic in aquaculture have a complete understanding of 
the mechanisms by which the treatment works, however several studies have 
demonstrated a disease reducing effect in challenge or field trials. 
 
2.2 Use of microorganisms for prevention of disease in aquaculture 
 
A range of bacteria has either been suggested and/or evaluated as biological control 
agents in aquaculture. Many of the proposed strains belong to the lactic acid bacteria 
(LAB) to the genus Vibrio, to the genus Bacillus or the genus Pseudomonas, although 
many other genera or species have also been tested. This section gives a brief overview 
of some of the in vivo studies conducted with probiotic bacteria. For further information of 
the use of probiotic in aquaculture see the following reviews (Gatesoupe 1999; Verschuere 
et al., 2000b; Irianto and Austin 2002; Gram and Ringø 2005; Balcazar et al., 2006; Vine et 
al., 2006). 
 
Several studies have evaluated the use of probiotic bacteria on grown fish, however, 
effective commercial vaccines are available for most fish pathogenic bacteria (Sommerset 
et al., 2005). Therefore the future focus of probiotic research should be aimed at problems, 
which cannot be solved with vaccines e.g. infectious diseases in production of fish larvae, 
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crustaceans and molluscs or diseases caused by bacteria where no vaccines are available 
(e.g. Flavobacterium psychrophilum). Investigations regarding cost benefit in the long term 
needs to be done, which will assure that it is an economically attractive way of decreasing 
infectious diseases. Since probiotic bacteria may not be effective in aquaculture in general, 
but may be effective in a specific production.  
 
2.2.1 Finfish  
 
Many different bacterial strains have been tested for their ability to reduce infectious 
diseases in finfish. All though positive results have been found, no specific strain(s) are 
broadly applied within finfish aquaculture.  
 
Finfish larvae  
The mortality of non-feeding turbot larvae (Scophthalmus maximus) was significantly 
reduced by eight out of 12 Roseobacter strains tested of which all showed antagonistic 
activity against Vibrio spp (Hjelm et al., 2004a). Also Makridis et al., (2005) found a 
positive effect of a Roseobacter strain on survival rate of gilthead sea bream larvae 
(Sparus aurata), but no significant difference was found between treatment with or without 
Roseobacter. One Roseobacter strain was tested in a challenge test against V. 
anguillarum. In turbot larvae receiving rotifers with both Roseobacter 27-4 and V. 
anguillarum the accumulated survival was significantly reduced compared to treatment 
with V. anguillarum alone (Figure 2) (Planas et al., 2006). Positive effects on the 
accumulated survival of turbot larvae have also been observed by addition of Vibrio 
mediterranei (Huys et al., 2001), Vibrio pelagius (Ringo and Vadstein 1998) and Lactic 
acid bacteria (LAB) (Gatesoupe 1994).  
 
Figure 2: Accumulated 
mortalities in turbot 
larvae. VR: larvae were 
fed with rotifers loaded 
with Roseobacter 27-4 
and V. anguillarum. V: 
larvae fed on rotifers 
loaded with V. 
anguillarum. Control: 
larvae fed with non-
enriched rotifers (Planas 
et al., 2006).  
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Grown finfish  
 
By adding a probiotic Vibrio alginolyticus strain, the survival increased in Atlantic salmon 
(Salmo salar L.) when challenged with Aeromonas salmonicida (from 0 to 82%), V. 
anguillarum (from 10 to 26%) and Vibrio ordalii (from 0% to 26%), however, no beneficial 
effect was found when challenged with Yersinia ruckeri (Austin et al., 1995). Using 
Carnobacterium spp. as a probiotic strain for Atlantic salmon, an increase in the survival 
was seen when challenged with A. salmonicida (from 0 to 20%), V. ordalii (from 23% to 
74%) and Y.ruckeri (from 42 to 71%), but here no effect was seen when challenged with V. 
anguillarum (Robertson et al., 2000). 
 
Several pseudomonas strains also have a disease reducing effect (Smith and Davey 1993; 
Spanggaard et al., 2001). The inhibition of V. angiullarum by Pseudomonas fluorescens 
AH2 shown in vitro was successfully repeated in vivo experiments with rainbow trout 
challenged with V. anguillarum. Here a significant reduction in mortality were seen for fish 
treated with AH2 (Figure 3A) (Gram et al., 1999). In vitro antagonism of P. fluorescens 
AH2 against Aeromonas salmonicida did however not confer Atlantic salmon protection 
against furunculosis as no differences were seen between treatment with and without AH2 
(Figure 3B) (Gram et al., 2001). These results show that a promising probiotic candidate in 
one system may not automatically be applied in a new system.  
 
Figure 3: Accumulated 
mortality of A: rainbow trout in 
infected with V. anguillarum and 
B: atlantic salmon infected with 
A. salmonicida. Both with and 
without probiotic treatment with 
P. fluorescens AH2. Control: 
infected with the pathogenic 
bacteria (Gram et al., 1999; 
Gram et al., 2001).  
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2.2.2 Crustaceans 
 
Marine shrimps are the dominant production in crustacean aquaculture. Today there is 
already a broad application of probiotic bacteria in commercial shrimp hatcheries. In 
general, most studies of probiotic bacteria for application in shrimp productions have 
focused on Bacillus strains. Commercial products such as BaoZyme-Aqua, Liqualife® and 
Promarine®, available for shrimp aquaculture, all contain one or several strain of Bacillus 
(Hong et al., 2005). Vibrio spp. is the most common cause of infections in shrimps 
industry. Moriarty (1998) compared survival of shrimps with and without addition of 
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Bacillus in the presence of luminous Vibrio strains. Mass mortality within 80 days was seen 
in cultures without Bacillus strains, whereas in the abundance of Bacillus strains the 
shrimps could be cultured for more than 160 days without problems. Likewise a positive 
effect on cultures of Penaeus monodon by exposing them to Bacillus subtilis BT23 or 
Bacillus S11 has been found. The addition of the Bacillus strains to shrimp cultures 
resulted in a reduced mortality when challenged with Vibrio harveyi (Rengpipat et al., 
2003; Vaseeharan and Ramasamy 2003). The disease reducing effect of the Bacillus 
strains may be a result of improvement of the water quality e.g. by removal of ammonia 
(Chen and Chen 2001; Farzanfar 2006). Commercial products containing Bacillus spp. do 
indeed guarantee a water quality improvement. If this is the only mode of action in 
decreasing shrimp mortality, the Bacillus strains will not be considered as probiotic 
bacteria based on the definition used in this thesis.  
 
2.2.3 Molluscs 
 
Several different strains have been tested for their ability to reduce the heavy losses, 
which is experienced within oyster production due to disease outbreaks. Gibson et al., 
(1998) investigated the use of Aeromonas media A199, capable of producing an 
antibacterial compound, on the pacific cupped oyster (Crassostrea gigas). A199 was able 
to control infections with Vibrio tubiashii, as all larvae died in the presence of V. tubiashii 
alone whereas survival was approx. 95% when adding a combination of V. tubiashii and 
A199.  
 
The marine Roseobacter strain BS107 had antagonistic activity in vitro against several fish 
and molluscs pathogenic bacteria. It was suggested that the inhibitory effect was displayed 
only in the presence of another bacterium as only supernatants from co-cultures gave 
inhibition zones in a well diffusion assay. Cell extracts of the Roseobacter strain lowered 
mortality rates of scallop (Pectin maximus) larvae in a challenge test with Aeromonas 
salmonicida. However, the presence of whole cells of the Roseobacter strain did not 
enhance survival of the larvae (Ruiz-Ponte et al., 1999). 
   
In a recent study by Macey and Coyne (2005) a probiotic supplement containing both 
yeast and bacteria strains improved the growth rate of Haliotis midae. When challenging 
the abalone with V. anguillarum, 62% of the probiotic fed animals survival compared to 
25% for non-treated animals, however, no statistic analysis was accomplished. 
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2.3 Isolation of probiotic bacteria 
 
Probiotic microorganisms used in aquaculture are found in several microbial groups of 
bacteria (Verschuere et al., 2000b; Gram and Ringø 2005), bacteriophages (Nakai and 
Park 2002), yeasts (Tovar et al., 2002) and microalgae (Austin et al., 1992). The focus of 
this thesis is on the use of bacteria as probiotic organism.  
 
For selection of effective probiotic bacteria, a collection of putative candidates is required. 
Such candidates can be isolated from the host or the environment in which the bacteria 
are supposed to exert their probiotic effect. However, there is no unequivocal identification 
that putative probiotics strains isolated from completely different environment to the 
cultured species or originating from very different habitats have a smaller success of being 
a probiotic bacteria (Verschuere et al., 2000b). Any collection of putative probiotic bacteria 
needs to be evaluated to find the optimal strain(s), however, no proven scientific rationale 
exists for the selection of the best probiotic species or strain (Gram and Ringø 2005; Vine 
et al., 2006). Conway (2006) listed several abilities, which are recommended to be 
included for the selection of functional probiotic strains. The list can be divided in in vivo 
effect e.g. that the probiotic candidates are non-toxic to the host and that it needs to have 
a demonstrable health effect. However these are not abilities, which are easily applied in 
screening methods. The in vitro abilities include antagonistic activity against pathogenic 
bacteria, survival and growth in situ and colonization potential. These are abilities, which 
have been used in screening protocols, even though there is no direct link between these 
abilities and the observed in vivo effects.  
 
The most common way to select probiotics is selecting organisms, which show in vitro 
antagonism against the pathogen, which is causing the problem (Westerdahl et al., 1991; 
Riquelme et al., 1997; Spanggaard et al., 2001; Hjelm et al., 2004b). When detecting 
antagonism in a well diffusion assay one cannot conclude that this will be produced in situ, 
since the growth media can influence the degree of in vitro inhibition (Olsson et al., 1992; 
Hjelm et al., 2004a) and growth substrates are typically very different from the in situ 
environment. Even though a bacteria has the ability to inhibit pathogens in vitro, adding the 
bacteria will not necessarily improve health of the aquatic organisms in an in vivo system 
(Gram et al., 2001; Spanggaard et al., 2001; Suomalainen et al., 2005). 
 
Testing pure cultures from fish environment, typically results in 4 - 28% having 
antagonistic activity against fish pathogenic bacteria (Westerdahl et al., 1991; Spanggaard 
et al., 2001). This selection procedure is very time consuming and screening directly for 
inhibiting strains, assuming that this is an important phenotype, will increase chances of 
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finding probiotic candidates. Replica plating is a rapid and easy way to screen multiple 
strains from environment by copying colonies from primary sample plates onto agar, which 
is cast with the pathogenic bacteria to be inhibited (Figure 4). By using replica plating 
27,500 colonies isolated from a turbot rearing facility were screened for antagonistic 
activity. 537 colonies were pre-selected as potential antagonists strains of which all were 
Gram-negative. 205 of these had stable antagonistic activity and of these 147 belonged to 
the Roseobacter while 48 belonged to the Vibrio genus (Hjelm et al., 2004a; Hjelm et al., 
2004b). Antagonistic Roseobacter strains have also been isolated from cultures of the 
scallop Pecten maximus (Ruiz-Ponte et al., 1998; Ruiz-Ponte et al., 1999; Ricardo et al., 
2004).  
 
Figure 4: Primary plate with 
bacteria from water (left) and 
replica plate where inhibitory 
colonies cause a clearing in 
the turbid growth of the fish 
pathogen, Vibrio anguillarum 
(Hjelm et al., 2004a). 
 
 
Colonization and growth within the gastrointestinal tract have also been applied as 
screening methods for probiotic bacteria, and a disease reducing effect has been 
observed for bacteria isolated by such an approach (Chabrillón et al., 2005; Chabrillón et 
al., 2006). Screening for colonization ability has been combined with screenings for 
antibacterial compounds (Olsson et al., 1992; Jöborn et al., 1997; Vine et al., 2004).  
 
2.4 Possible mode of action of probiotic bacteria 
 
Although some bacteria have probiotic effects in aquaculture productions, the mechanisms 
by which such treatment works is not known. No reports have completely elucidated the 
exact mode of action in vivo for the probiotic bacteria used in aquaculture. To elucidate the 
mode of action(s) knock out mutants in specific genes within the probiotic bacteria can be 
used. The following section describes the suggested mode of actions among fish probiotic 
bacteria. There is a high likelihood that a diseases reducing effect of a probiotic bacteria 
will be caused by a combination of these different suggested mode of actions.  
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2.4.1 Production of antibacterial compounds 
 
Antagonistic compounds are defined as chemical substances produced by 
microorganisms (in this case bacteria) that are toxic (bactericidal) or inhibitory 
(bacteriostatic) towards other microorganisms. The presence of bacteria producing 
antibacterial compounds in the intestine of the host, on its surface, or in its culture water is 
thought to prevent proliferation of pathogenic bacteria and even eliminate these. The 
antibacterial compounds can be divided into compound with a direct (e.g. antibiotic, 
bacteriocins) or indirect (e.g. siderophore) effect on the pathogen. Siderophore are dealt 
with in the next section. Lactic acid bacteria often produce bacteriocins, however, these 
are often only active against closely related species (Klaenhammer 1993) and most 
pathogens involved in aquaculture are Gram-negative and bacteriocins from LAB may 
therefore not inhibit fish pathogenic bacteria.  
 
Probiotic bacteria suggested as probiotic treatment in aquaculture can produce both 
proteinaceous and non-proteinaceous substrates (Table 1). The structure of the 
antibacterial compound is often not elucidated and their mode of action has not been 
reported. Furthermore none of these reports demonstrate that the antibacterial compound 
is produced in vivo. This will be of significant importance if production of these compounds 
is the mode of action. If the production of antibacterial compound is the only mode of 
action, it is possible that the pathogen eventually will develop resistance towards the 
compound. This will result in an ineffective treatment. The risk of the pathogen to develop 
resistance against the active compound has to be evaluated, to assure a stable effect of 
the probiotic bacterium. 
 
2.4.2 Nutrient competition  
 
The bacteria inhabiting the aquaculture environment compete for available nutrients and 
this is suggested as a mode of action for probiotic bacteria. The most described 
competition for nutrients is the competition for iron by production of siderophores. 
Siderophores are low-molecular-weight ferric ion-specific chelating agents. Production of 
siderophores has been found in several Pseudomonas strains suggested to be probiotic 
strains (Smith and Davey 1993; Gram et al., 1999). A positive correlation was found 
between the production of siderophores and the protective action of P. fluorescens AH2 
against V. anguillarum (Gram et al., 1999). Furthermore by using arbitrarily PCR-amplified 
gene transcripts it was concluded that production of siderophores was the cause of 
inhibition in V. anguillarum (Holmstrom and Gram 2003). These results suggest that 
competition for free iron is in fact the mode of action for P. fluorescens AH2 found in the in 
vivo experiments, however production of siderophores has not been demonstrated in vivo.  
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Table 1: Characteristic of the antibacterial compound produced by strains suggested as probiotic bacteria for use within aquaculture 
  
Strain Fish pathogens Inhibited  Compound Parameters influencing 
the production 
Mode of action Reference 
Roseobacter 27-4 Vibrio spp. (seen table 4) Tropodithietic acid Only produced in stationary 
phase under static growth 
conditions 
Unknown Bruhn et al., 
2005b 
Roseobacter CECT 
5719 and. CECT 
5718 
Vibrio anguillarum Five cyclic dipeptides  - Unknown Ricardo et al., 
2004 
Vibrio sp NM10 Flavobacterium spp. 
Pseudomonas spp. and Vibrio 
spp. 
Heat labile proteinaceous > 5 
kDa  
Seawater in media, 
incubation time, temperature 
and pH 
Unknown Sugita et al., 
1997 
Micrococcus MCCB 
104 
Vibrio spp. and Aeromonas 
spp. do mot inhibit Bacillus 
spp., Pseudomonas spp. and 
Vibrio splendidus 
Heat labile non-proteinaceous  Produced in the late 
exponential and stationary 
phase 
Unknown  Jayaprakash 
et al., 2005 
Pseudomonas PS-
102 
Vibrio spp. and Aeromonas 
spp. 
Heat stable non-
proteinaceous  
Produced in the late 
exponential and stationary 
phase  
Unknown1  Vijayan et al., 
2006 
Pseudoalteromonas 
strain X153 
Vibrio spp. no effect on yeast 
and fungus 
87 kDa Antimicrobial protein  - Unknown Longeon et 
al., 2004 
Pseudomonas I-2 Vibrio spp. Heat stable >10 kDa non-
proteinaceous  
Production was only seen in 
the stationery phase, and 
production was effected by 
salt conc. and pH. 
Unknown Chythanya et 
al., 2002 
Vibrio C33 Vibrio spp. Aeromonas 
hydrophila 
Several, one was identified as 
an aliphatic hydroxyl ether 
- Unknown Jorquera et 
al., 2000 
Aeromonas media 
A199 
Aeromonas spp., Vibrio spp., 
Yersinia ruckeri and P. 
damsella 
Bacteriocin-like - Unknown  Gibson et al., 
1998 
Roseobacter BS107 Aeromonas spp., Vibrio spp.  Heat stable proteinaceous Inhibitory activity were only 
detected from co-cultures 
Unknown Ruiz-Ponte et 
al., 1999 
1 the mode of action was not elucidated however, siderophores were produced by the strain hence the inhibitory activity could be due to 
this production. 
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Production of siderophores has been recognized as an important factor in the disease 
suppression ability of fluorescent Pseudomonas spp. used as biocontrol cultures against 
plant pathogens (O´Sullivan and O´Gara 1992).  
 
Since the bacterial community associated with aquaculture environment is dominated by 
heterotrophic bacteria, competition for organic substrates such as carbon and energy 
sources will take place. A bacterial strain SK-05 was selected based on its ability to grow 
in organic-poor environment, and the strain inhibited the growth establishment of V. 
alginolyticus in diatom culture. Since SK-05 had no inhibitory effect against V. alginolyticus 
in an in vitro system, it was concluded that SK-05 out-competed V. alginolyticus by 
maintaining a low organic concentration in the culture unsuitable for V. alginolyticus growth 
(Rico-Mora et al., 1998).  
 
In a study by Verschuere et al., (2000a) V. alginolyticus were used as the probiotic 
bacterium. V. alginolyticus produced no extracellular antagonistic compounds against the 
Artemia spp. pathogen V. proteolyticus, even though the strain was able to have a 
negative effect on the colonization of V. proteolyticus in the culture water. The protective 
effect was only found when using living cells and therefore it was suggested that the mode 
of action were competition for substrates and available energy.   
 
2.4.3 Competition for attachment sites  
 
Successful colonization and invasion of the host by pathogenic bacteria rely on the ability 
to attach to the invasion sites and proliferate. If the pathogenic bacteria are prevented in 
this attachment by e.g. probiotic bacteria, chances for a successful invasion will be 
reduced. Several studies use attachment and growth, mostly to/in the mucus, as one of 
the criteria when selecting probiotic bacteria (Olsson et al., 1992; Chabrillón et al., 2005; 
Chabrillón et al., 2006).  
 
Vibrio strain Pdp11 was selected as a probiotic candidate based on its ability to adhere in 
high numbers to the intestinal mucus. The strains showed no antagonistic activity against 
V. anguillarum in an in vitro assay. However a significant reduction in mortality was seen 
for Gilthead seabream challenged with V. anguillarum when adding Pdp11. It was 
suggested that the mode of action was colonization of the intestinal mucus and thereby 
preventing invasion of V. anguillarum (Chabrillón et al., 2006). 
 
Members of the Roseobacter clade are the first to attach to surfaces in costal environment, 
and several members of the clade have been suggested as probiotic bacteria (Ruiz-Ponte 
et al., 1999; Ricardo et al., 2004; Luis et al., 2004; Hjelm et al., 2004a; Bruhn et al., 2005b; 
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Belas et al., 2006). Roseobacter 27-4 showed high attachment capability and formation of 
biofilm under growth conditions, which facilitates its production of an antibacterial 
compound (Bruhn et al., 2005b). This combination of phenotypes is suggested to be 
perfect for a probiotic bacterium. However, when administrating Roseobacter 27-4 through 
enrichment rotifers, the bacterium did not colonise the larval gut or intestine and was 
mostly detected in the culture water (Planas et al., 2006). Showing that high attachment to 
inert surfaces in general do not necessary give colonization abilities.   
 
2.4.4 Quorum quenching  
 
Blocking the virulence phenotypes in fish pathogenic bacteria may also be a mode of 
action of probiotic bacteria. Virulence is under the control of a so-called quorum sensing 
(QS) system in a number of human and plant pathogenic bacteria (Whitehead et al., 
2001). However, QS systems also regulate suspected virulence phenotypes in some fish 
pathogenic bacteria (Swift et al., 1999; Freeman and Bassler 1999; Croxatto et al., 2002; 
Kim et al., 2003). QS systems rely on the ability of the bacteria to monitor their population 
cell density by release of small molecular mass signal molecules (mainly acylated 
homoserine lactones (AHLs) for Gram-negative bacteria) into the environment. The 
bacteria can sense their cell density by monitoring the concentration of signal molecules 
(by using AHL receptors), and thereby trigger specific phenotypes (for example virulence 
factors) at a particular cell density (Whitehead et al., 2001). AHLs compounds are 
produced by many fish pathogenic bacteria (Bruhn et al., 2005a). The QS systems can be 
disrupted by two different methods, interference with the AHL- receptors or by degrading 
the signal molecule.  
 
Several molecules can react with the QS system e.g. cyclic dipeptides (Holden et al., 
1999) long chain AHL molecules (McClean et al., 1997) and the so-called quorum sensing 
inhibitors (QSI). These molecules will block the AHL regulated systems, and thereby the 
expression of any virulence phenotype, which is regulated by QS, at concentrations that 
does not affect the growth of the bacteria. QSI compounds have successfully been applied 
to reduce mortality of fish and shrimp during challenge trials against pathogenic bacteria 
(Manefield et al., 2000; Rasch et al., 2004; Defoirdt et al., 2006). However, addition of QSI 
compounds is not always affective, as a known virulence factor in a high AHL producing 
strain of Yersinia ruckeri was unaffected by addition of QSI compounds (Kastbjerg et al., 
2006). 
 
Both cyclic dipeptides (Jørn Smedsgaard personal communication) and long chain AHL 
molecules (Bruhn et al., 2005b) are produced by Roseobacter 27-4 and other potential QS 
inhibitor compound have been detected within extracts of Roseobacter 27-4. Rasmussen 
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et al., (2005) developed a bioassay for testing extracts or compounds for QSI activity. If 
Quorum quenching is a mode of action for probiotic bacteria this bioassay is suitable for 
screening after bacteria which produce QSI compounds. A positive reaction is seen from a 
static grown supernatant of Roseobacter 27-4 (Figure 5), but also sterile media used at 
negative control gave a positive reaction. Indicating that no QSI compound which can be 
detected by this bioassay, is produced by Roseobacter 27-4 (Unpublished results by 
Bruhn and Rasmussen).  
 
Media  Shaken extract  Shaken supernatant  Static supernatant 
 
Figure 5: Supernatant from static and shaken grown cultures of Roseobacter 27-4 and extracts of 
a static culture tested in the QSI selector. Positive reaction (formation of blue colour) is seen for the 
static grown supernatant, however, also positive reaction is seen for the sterile media used at 
negative control.  
 
Enzymatic degradation of AHL compounds are widespread among Bacillus spp., which 
produce specific AHL-lactonases that destroys the AHL molecule and thereby disrupt the 
QS system of other bacteria (Dong et al., 2000; Dong et al., 2001). Genes encoding AHL-
lactonases have been found in several strains of Bacillus thuringiensis, which is used for 
biocontrol against plants pathogens (Lee et al., 2002). Furthermore, AHL-degrading 
Bacillus spp. can reduce virulence factors in the plant pathogens Erwinia carotovora and 
Agrobacterium tumefaciens (Molina et al., 2003). It can be suggested that degradation of 
AHL compounds may act as a mode of action for probiotic Bacillus used e.g. in shrimps 
farms. 
 
2.5 Administration of probiotic bacteria 
 
There are several ways in which probiotic cultures can be delivered to the aquaculture 
units. Vine et al., (2006) conclude that methods to deliver the probiotics to the larvae have 
not been optimized to achieve enhanced effects. Probiotic bacteria have been added by:  
 
• Bathing the host in bacterial suspension 
• Addition to diet e.g. by enrichment of live food (artemia/rotifers) 
• Addition to culture water 
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There are only few studies in which the fish/animal has been bathed in a bacterial 
suspension of probiotic bacteria. Riquelme et al., (1997) found a disease reducing effect 
by bathing Argopecten purpuratus larvae in suspension of probiotic bacteria, however also 
ineffectual bathing has been reported (Suomalainen et al., 2005). Most studies have 
administrated the probiotic bacteria to aquaculture by adding them to the culture water or 
to the diet. Grisez et al., (1996) found that the important fish pathogen V. anguillarum was 
able to invade juvenile turbot through the intestine. In faecal extract from turbot juveniles 
the growth of V. anguillarum was inhibit by Carnobacterium cells. They concluded that the 
turbot intestinal tract and contents can serve as an enrichment site for V. anguillarum, and 
the use of intestinal bacteria with antagonistic activity against vibrios may be used to 
reduce the load of fish pathogenic Vibrio in turbot hatcheries (Olsson et al., 1998). Several 
studies have supplemented the diet with probiotic bacteria (Table 2). 
 
Table 2: Minimum transience of probiotic candidates in the gut of fish and shellfish. j: juveniles, l: 
larvae (modified after Gatesoupe 1999). 
 
Microbe Host  Minimum persistence Reference  
Ae. Media Crassostrea gigas (l) 2 days (20ºC) Gibson et al., 1998 
Aeromonas sp. Sc. Maximus (l) 14 days (15-20ºC) Munro et al., 1995 
Ca. divergens G. morhua (l) 9 days (8ºC) Strom and Ringo 1993 
Carnobacterium sp. Onchorhyncus mykiss (j) 4 days (11ºC) Jöborn et al., 1997 
V. alginolyticus Sa. Salar (j) 21 days (15ºC) Austin et al., 1995 
Vibrio Pelagius Sc. Maximus (l) 14 days (17-20ºC) Ringo et al., 1996 
Roseobacter 27-4  Sc. Maximus (l) 3 days (18ºC) Pérez-Lorenzo et al., 2006 
 
In general, probiotic bacteria do not colonize and persist in the host and if a long-term 
exposure is required, they have to be supplied repeatedly. Probiotic bacteria such as 
Roseobacter 27-4 are detected in the culture water rather than in the intestine of the host, 
suggesting that adding the bacterium to the feed may not be the most effective way of 
adding this bacterium.  
 
The skin has been suggested to be an important invasion site for fish pathogens such as 
F. psychrophilum, V. anguillarum and A. sakmonicida and especially skin damage 
enhances the infection by these pathogens (Svendsen and Bogwald 1997; Spanggaard et 
al., 2000; Madetoja et al., 2000). Adding the probiotic bacteria to the culture water could 
therefore be an effective way of adding probiotic bacteria. Smith and Davey (1993) 
concluded that P. fluorescens exerted its effect from the host´s exterior, since the strain 
did not significantly invade the fish following bath treatment. Also Spanggaard et al., 
(2000) suggested that the protective effect observed when using Pseodumonas AH2 
against vibriosis is caused by bacterial antagonisms on the skin. Roseobacter 27-4 was 
found to have a protective effect on turbot larvae, however, the bacteria were almost only 
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detected in the culture water even though administrated through live food. This suggests 
that the antagonistic activity also for this bacterium is on the host’s exterior.  
 
As Roseobacter strains can be isolated from tank walls in costal fish farms (Hjelm et al., 
2004b; Choi and Cho 2006), colonization of tank walls may be suggested as a novel way 
of administrating probiotic Roseobacter, as biofilm within rearing tanks can be a reservoir 
for potentially pathogenic bacteria (Bourne et al., 2006). In this thesis it is hypothesised 
that Roseobacter may exert its effect as a probiont when colonizing the inert surfaces of 
the aquaculture units.  
 
2.6 Quantification of probiotic and pathogenic bacteria in aquaculture 
 
Studying the interaction between probiotic bacteria and pathogens requires that each can 
be specifically quantified. If the probiotic bacteria are thought to exert its effect during 
colonization of tank walls, quantification of the bacterium during attachment is essential for 
evaluating the probiotic treatment.  
 
Quantification of the probiotic bacterium and pathogenic bacteria both within the host and 
in the culture water is frequently done by growing the bacteria on selective or non-selective 
substrates (Gatesoupe 1994; Gildberg and Mikkelsen 1998; Riquelme et al., 2000; 
Riquelme et al., 2001; Rengpipat et al., 2003; Planas et al., 2006). The disadvantage of 
using this approach is that it is not strain specific e.g. it will not distinguish between 
pathogenic and non-pathogenic Vibrio. Furthermore, if plate counts are to be used for 
quantification of bacteria attached to an inert surface one must remove the bacteria before 
quantification (Dewhurst et al., 1986; Zips et al., 1990; Bourion and Cerf 1996). It is 
however impossible to know if all the bacteria have been removed or if some has been 
killed during the removal process. 
 
By using Immunohistochemistry probiotic and pathogenic bacteria can be determined 
within the host (Gildberg and Mikkelsen 1998; Planas et al., 2006), which will give 
information regarding colonization capabilities and invasions sites. However, 
immunohistochemistry is time-consuming and not suitable for quantification.  
 
Fluorescent in situ hybridization (FISH), can be used to investigate the bacterial diversity in 
aquatic animals (Hernandez-Zarate and Olmos-Soto 2006) and is suggested to be an 
important tool in future investigations of bacterial density in aquaculture. By using this 
method it is possible to investigate if non-cultureable bacterial strain is important in 
aquaculture production. Furthermore, fluorescence microscopy is used to quantify bacteria 
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attached to surfaces and in biofilms (Moller et al., 1995). In general, these methods have 
the disadvantage that a low number of attached bacteria cannot be quantified. 
Furthermore, quantification of a mixed species biofilm with several bacteria is difficult when 
using methods based on microscopy, even when different rRNA probes are available.  
 
Real-time PCR have been used for quantification of humans pathogens in raw oysters 
(Lyon 2001; Campbell and Wright 2003; Blackstone et al., 2003) and Adams and 
Thompson et al., (2006) suggested that Real-time PCR offers an opportunity to quantify 
low levels of fish pathogenic bacteria. Real-time PCR also offers possibilities for 
quantification of bacteria adhered to the gastrointestinal mucosa (Huijsdens et al., 2002) 
and quantification of both pathogenic and probiotic bacteria during competition for 
attachment on intestinal epithelial cells (Candela et al., 2005), indicating that the method 
can be a strong tool for detecting interactions also within aquaculture. Real-Time PCR has 
also been used for quantification of bacteria in biofilm in e.g. dental plaque (Yoshida et al., 
2003) or directly on an inert surface (Guilbaud et al., 2005). 
 
2.6.1 Development of a Real-time PCR method for quantification of Roseobacter 27-
4 and Vibrio anguillarum  
 
As part of this work, a Real-time PCR procedure was developed for quantification of 
probiont and pathogen. Specific primers for Real-time PCR were designed within the virA 
gene for V. anguillarum (Jensen et al., 2005), primers designed in the 16S rRNA gene for 
Roseobacter 27-4 did not detect any fish pathogenic bacteria, however, five other bacteria 
from the Roseobacter clade gave positive, albeit delayed, detection (Bruhn et al., 2006). 
The primers designed for Roseobacter 27-4 can therefore only be used within a model 
system, as different strain of Roseobacter can be isolated for costal fish farms with high 
similarity within the 16S rRNA gene (Choi and Cho 2006).  
 
The Real-time PCR quantification relies on a standard curve comparing either DNA 
concentration to amplification cycle (Ct value) or colony counts to amplification cycle 
(Figure 6). We concluded (Bruhn et al., 2006) that the cfu-Ct curve was required to reflect 
cell counts during growth of Roseobacter 27-4. 
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Figure 6: Standard curve representing the 
correlation between CFU/ml of Roseobacter 
27-4 and Ct value detected with the Real-
Time PCR method. ■ dilution of cells, ■ 
dilition of DNA (Bruhn et al., 2006). 
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The silica membrane used for DNA purification might be overloaded when high cell density 
samples are extracted. This will result in a lower efficiency at high cell densities compared 
to extracting from lower cell density samples. The result of this difference is seen in Figure 
6. Guilbaud et al., (2005) prepared a standard curve by comparing Ct-values of DNA 
extractions from adherent cells with plate count from cells removed by sonication. A Ct-
CFU/ml standard curve based on dilutions of Listeria monocytogenes DNA was different 
from the standard curve based on removal and quantification of the adherent cells in a 
similar manner (Bruhn et al., 2006). Hence, standard curve based on dilution of cells 
should be used when quantifying bacteria. By using a standard curve (R2 = 0.98) for V. 
anguillarum it was possible to quantify V. anguillarum during growth under static and 
shaken conditions (Jensen et al., 2005) in a similar manner as for Roseobacter 27-4 
(Figure 7).  
 
Cell counts based on Ct Real-time PCR measurements were equal to DAPI stains of 
stainless steel surfaces (Figure 7; Bruhn et al., 2006). The Real-time PCR method 
detected as low as 35 CFU/cm2, which is much lower then other reports where approx. 104 
cells per cm2 are the detection limit (Guilbaud et al., 2005; Jensen et al., 2005). The 
difference in sensitivity may partly be explained by the copy number of the detected gene 
as up to 4 16S rRNA genes have been reported in bacteria related to Roseobacter 27-4 
(Fogel et al., 1999; Klappenbach et al., 2000) and only one gene copy is expected for the 
detected genes in V. anguillarum and L. monocytogenes. 
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Figure 7: Quantification of Roseobacter 27-4 in 
liquid culture (Marine Broth) and attached to 
stainless steel coupons, A) under static 
conditions and B) under shaken conditions. □ 
CFU/ml determined by plate counts, ■ CFU/ml 
determined by Real-Time PCR (in duplicates), 
○ CFU/cm2 attached bacteria determined by 
DAPI staining, ● CFU/cm2 attached bacteria 
determined by Real-Time PCR (in duplicates) 
(Bruhn et al., 2006). 
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Interaction has been observed in liquid cultures when growing Roseobacter 27-4 together 
with V. anguillarum, as cell density of V. anguillarum decreased when Roseobacter 27-4 
reached high cell counts (Figure 8). Interaction between bacteria is also seen during 
attachment and in biofilms (Bourion and Cerf 1996; Christensen et al., 2002; Hassan et al., 
2004) and antagonistic interaction during attachment has been observed with bacteria 
belonging to the Roseobacter clade (Rao et al., 2005; Rao et al., 2006). 
 
If the Real-time PCR procedure is to be applied for interaction experiments both in culture 
and on inert surfaces, the challenge is to remove or inactivate DNA from dead cells as 
dead bacteria may still be detected by Real-Time PCR. V. anguillarum density decrease 
during interaction with Roseobacter 27-4 (Figure 8 and Bruhn et al., 2005b) and removal of 
DNA from dead cell will be necessary if interaction is to be measured. By using Ethidium 
monoazide (EMA) it is possible to distinguish between viable and dead cells when 
quantifying bacteria with Real-time PCR (Nogva et al., 2003; Rudi et al., 2005; Wang and 
Levin 2006). The principle is that when EMA is added to samples containing both living 
and dead cells it will bind to DNA within dead cells (cells with damaged membranes). By 
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exposing the samples to light leads to covalent bindings between EMA and DNA, which 
inactivate the DNA for PCR amplification and eliminate free EMA. 
 
DNase treatment of samples prior to DNA extraction has also been successfully applied to 
remove DNA from dead cells. A one-log reduction in estimated cell counts of Vibrio 
choleras was found when comparing DNase treated with non treated sampled (Lyon 
2001).  
 
Figure 8: Individually growth of V. 
anguillarum and in combination with 
Roseobacter 27-4 in Marine broth 
(unpublished results by Bruhn, Melchiorsen 
and Gram).  
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Attempts to remove or inactivate free DNA were done on heat treated V. anguillarum cells 
with both DNAses and Ethidium monoazide, however the Ct value remained at the same 
levels before and after heat treatment even thought the CFU/ml decreased (Jensen et al., 
2005). Therefore further optimization of the method is needed before interaction 
experiments between Roseobacter 27-4 and V. anguillarum can be performed.  
 
2.7 Conclusions from chapter 2 
 
The dramatic growth in the aquaculture sector has emphasized the importance of fish 
disease control. Bacterial diseases are important constraints and may be treated with 
antibiotics. However, due to the risk of development and transfer of antibiotic resistance, 
alternative disease control measures must be implemented. Several studies have 
demonstrated a disease reducing effect of probiotic bacteria in fish rearing and one of 
several promising candidates is Roseobacter 27-4 a marine bacterium belonging to the 
Roseobacter clade. 
 
A disease reducing effect is often only found in the presence of high numbers of probiotic 
bacteria. Furthermore, the probiotic bacteria do in most cases not colonize the host or 
21 
culture water, hence they have to be supplied repeatedly. This may be a limitation in the 
widespread use of probiotic bacteria. Creating a stable long-term beneficial microbiota in 
aquaculture environments would be an advantage. It is suggested in this thesis that 
Roseobacter 27-4 exerts its anti-pathogenic effect during biofilm formation at the tank 
walls, thus colonization of surfaces may be a novel way of administrating probiotic bacteria 
such as Roseobacter 27-4. A Real-time PCR procedure is presented as a method for 
evaluating the effect of surface colonized probiotic bacteria. 
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3 Tropodithetic acid produced by members of the Roseobacter 
clade 
 
Several Roseobacter strains have antibacterial activity and the production of antibacterial 
compounds are in this thesis suggested as the mechanism for the disease reducing effect 
of Roseobacter 27-4, when added to Vibrio infected turbot larvae. Hence, the nature of the 
antibacterial compound, its synthesis and how it is regulated needs to be elucidated as this 
will be significant in understanding how Roseobacter 27-4 acts as a probiotic organism. 
The effect of the antibacterial compound on eukaryotic and prokaryotic cells will be 
discussed, as this is important knowledge if the production of antibacterial compound is to 
be enhanced. Also, the interaction with eukaryotic cells and animals is an important 
element of a risk assessment. 
 
3.1 Antibacterial compound produced by Roseobacter 
 
Several members of the Roseobacter clade produce antibacterial compounds (Ruiz-Ponte 
et al., 1999; Wagner-Döbler et al., 2004; Brinkhoff et al., 2004; Ricardo et al., 2004; Luis et 
al., 2004; Hjelm et al., 2004a; Rao et al., 2005; Martens et al., 2006a; Bruhn et al., 2007), 
however, this is not a general phenotype as about 50% of screened strains have no 
antagonistic activity (Martens et al., 2006a; Bruhn et al., 2007). Buchan et al., (2005) 
divided the Roseobacter clade into 41 lineages and production of antibacterial compounds 
is not linked to one specific lineage, but several positive strains belong to the so-called 
RGALL lineage; the Roseobacter gallaciensis lineage.  
 
Several different compounds produced by members of the Roseobacter clade have 
antibacterial activity. Roseobacter strain BS107 produce an antibacterial proteinaceous 
molecule active against Vibrio spp. Aeromonas spp. and Acinetibacter spp. (Ruiz-Ponte et 
al., 1999). Five cyclic dipeptides produced by two Roseobacter strains inhibited V. 
anguillarum (Ricardo et al., 2004) and also Wagner-Dobler et al., (2004) detected 
antagonistic cyclic dipeptides and tryptanthrin in a member of the Roseobacter clade, 
Oceanibulbus indolifex.  
 
Antagonistic activity is found in bacteria closely related to Phaeobacter gallaeciensis 
(Brinkhoff et al., 2004; Luis et al., 2004; Hjelm et al., 2004a; Hjelm et al., 2004b; Rao et al., 
2005; Bruhn et al., 2005b), recently reclassified from Roseobacter gallaeciensis (Martens 
et al., 2006b). The antibacterial compound produced by Rhaeobacter inhibens T5, a 
member of the Roseobacter clade, is tropodithietic acid (TDA) (Figure 9) (Liang 2003; 
Brinkhoff et al., 2004). The structure of the antibacterial compound found in Roseobacter 
23 
27-4 was elucidated (Bruhn et al., 2005b), but it was not possible to distinguish between 
thiotropocin and tropodithietic acid (Figure 9) based on UV spectra and LC-MS-data. Both 
of these compounds may have antibacterial activity. 
 
Figure 9: Structure of the antibacterial 
compounds Thiotropocin and 
Tropodithietic acid.  
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Thiotropocin is produced by a Pseudomonas strain (Kintaka et al., 1984; Tsubotani et al., 
1984) and a Caulobacter strain (Kawano et al., 1997; Kawano et al., 1998). The structure 
of thiotropcin was not determined on the natural product but on a derivative thereof and 
when crystallizing the natural product directly, only tropodithietic acid was detected 
(Professor Dr. A. Zeeck personal communication; Liang 2003; Laatsch 2006). The 
antibacterial compound produced by both Roseobacter 27-4 and Silicibacter TM1040 has 
identical UV spectra (Figure 10) and the mass corresponds to the TDA found in R. 
inhibens T5 (Liang 2003; Bruhn et al., 2005b; Geng et al., 2007). This likely demonstrates 
that TDA is produced by these strains. Also a Phaeobacter gallaeciensis strain isolated 
from the surface of the marine alga Ulva lactuca, probably produces TDA (Rao et al., 
2005).  
 
It is not unlikely that the TDA producing Caulobacter strain PK654 (Kawano et al., 1997; 
Kawano et al., 1998) is actually a Roseobacter strain, as all phenotypic tests corresponded 
with Roseobacter strains and the strain produce a brown pigment, which is also found for 
TDA producing Roseobacter strains (Brinkhoff et al., 2004; Bruhn et al., 2005b; Bruhn et 
al., 2007). In addition the GC% of the strain does not match other Caulobacter strains 
(Kawano et al., 1997), but is similar to several Roseobacter strains.  
 
TDA is not a stable compound and its activity declines with increasing temperature. The 
antibacterial activity in sterile culture supernatant containing TDA decreases over time at 
temperatures from 5°C to 37°C and no activity was measured after 8 days at 25°C. 
However, TDA is not inactivated by exposure to different pH values (Bruhn et al., 2005b). 
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Figure 10: HPLC-DAD analysis 
showing the chromatogram of 
0.20 µm filtered supernatant of 
Silicibacter TM1040 (upper) 
and Roseobacter 27-4 (lower). 
The UV spectra of the 
compound eluting at 4.2 min. 
have identical UV spectra with 
tropodithietic acid from 
Rhaeobacter inhibens T5 
(Geng et al., 2007). 
 
 
 
3.2 Effect of TDA on eukaryotes and prokaryotes 
 
Several reports have demonstrated that TDA affects both eukaryotes and prokaryotes 
(Kintaka et al., 1984; Tsubotani et al., 1984; Kawano et al., 1998; Liang 2003; Hougaard et 
al., 2006; Bruhn et al., 2007). However, slightly contradictory results have been published 
in terms of the sensitivity of different organisms. For instance, Candida albicans was the 
most sensitive organism tested by Liang (2003), while Kazuhiko et al., (1984) found C. 
albicans to be almost unaffected by TDA. The growth substrate affects the amounts of by-
products that potentially can contaminate the product of interest (Heidorn 2002) and as 
TDA has been extracted from cultures of TDA producing strains, different culture 
substrates may explain some of the difference found. By-products are best avoided by 
growing the TDA producing strain in a defined media with the amino acids L-phenyalanine 
and L-histidine as single amino acids (Heidorn 2002). Such a substrate was not used for 
growing the TDA producing strains Pseudomonas (Kintaka et al., 1984) and Caulobacter 
(Kawano et al., 1998) before purification of TDA.  
 
3.2.1 Interaction with eukaryotes  
 
Several fungi, yeast and algae are sensitive to TDA, however, fungi and yeast seem less 
sensitive as compared to algae (Kintaka et al., 1984; Kawano et al., 1997; Liang 2003). No 
toxic effect was observed when colonic carcinoma Caco-2 cells were grown in the 
presence of supernatant containing TDA (Hougaard et al., 2006), but the carcinoma cells  
HM2, MSF7 and HEL G2 were inhibited and cell numbers reduced when they were grown 
in the presence a of high concentration (>10µg/ml approx. 50µM) of TDA (Liang 2003). 
Non-carcinoma human cells were more sensitive, as strong inhibition in proliferation was 
found in concentrations at 1-2 µM TDA (Kawano et al., 1998). Although TDA affects 
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mammalian cells, they seem less sensitive than bacteria cells, as supernatant containing 
TDA in most cases is sufficient to inhibit or kill bacterial cells (Bruhn et al., 2005b; Bruhn et 
al., 2007). 
 
Culture supernatant containing TDA causes no adverse reactions in zebrafish embryos 
and high concentration of supernatant resulted in lower mortality as compared to addition 
of sterile media (Table 3). Similar result was found for turbot larvae (Planas et al., 2006). 
Caenorhabditis elegans was also unaffected by addition of sterile TDA containing 
supernatant (Hougaard et al., 2006). However, Liang (2003) found that C. elegans was 
indeed affected when exposed to TDA with an IC50 of 25 µg/ml. High concentration of TDA 
also affected both Artemia salina and mice. One mg/ml TDA caused 100 % mortality of A. 
salina (Liang 2003) and the acute toxicity (LD50) of TDA in mice was 50-100 mg/kg by oral 
administration and 8 mg/kg by subcutaneous injection (Kintaka et al., 1984). These results 
indicate that it is unlikely that TDA, if produced in the marine environment, will have any 
negative effect on aquatic organisms. Members of the Roseobacter clade are in general 
non-toxic to higher organisms in the marine environment, however some members are 
suggested to cause juvenile oyster disease (JOD), all though no toxins have been 
identified (Boettcher et al., 1999; Boettcher et al., 2000; Boettcher et al., 2005).  
 
Table 3: The number of surviving zebrafish embryos exposed to dilutions of TDA containing 
supernatant from Silicibacter TM1040 or Roseobacter 27-4 (Belas et al., 2006).  
 
Living zebrafish embryos out of six  
Dilution of supernatant 
Time Supernatant from  
1/4 1/8 1/16 1/32 1/64 
Silicibacter TM1040  0 0 6 6 6 
Roseobacter 27-4  0 0 6 6 6 
Marine broth 0 0 0 0 6 
24 hours 
       
Silicibacter TM1040  0 0 6 5 6 
Roseobacter 27-4  0 0 6 6 6 
48 hours 
Marine broth 0 0 0 0 6 
 
3.2.2 Interaction with prokaryotes 
 
All bacteria tested so far are sensitive to TDA (Table 4). In general, a Roseobacter 
supernatant containing TDA is sufficient to inhibit other bacteria, but members of the 
Roseobacter clade and a few other strains are only inhibited when exposed to extracts 
with higher concentration of TDA. The sensitivity seems to be independent of the Gram-
reaction of the target cell. pH affected the sensitivity of the bacteria, as increasing pH in 
the assay media decreased the sensitivity (Kintaka et al., 1984). 
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Table 4: Inhibition of Gram-positive and Gram-negative bacteria by raw sterile filtered 
supernatants from TDA producing bacteria or by extracts or purified TDA (Kintaka et al., 1984; 
Tsubotani et al., 1984; Liang 2003; Brinkhoff et al., 2004; Bruhn et al., 2005b; Hougaard et al., 
2006; Bruhn et al., 2007). 
 
Gram negative Species no. of 
strains 
Sensitivity1 Gram positive Species no. of 
strains 
Sensitivity
Acinetobacter 
calcoaceticus 
1 ++ Actinobacteria 2 ++ 
Bacteroides fragilis 1 + Bacillus spp 5 ++ 
Citrobacter freundii 1 ++ Clostridium  1 ++ 
E. coli 3 ++ Listeria monocytogenes 5 ++ 
Flavobacteria 3 ++ Mycobacterium marinum 1 + 
Halomonas spp. 1 ++ Staphylococcus aureus 8 ++ 
Klebsiella pneumoniae 1 ++    
Proteus spp. 3 ++    
Pseudomonas spp. 9 ++2    
Roseobacter clade  17 +    
Salmonella spp. 6 ++2    
Serratia marcescens 1 ++    
Shewanella spp. 6 ++    
Vibrio spp. 18 ++2    
1 ++ inhibited by supernatant from TDA producing strains or low concentration of TDA, + only 
inhibited by extracts from TDA producing strains or high concentration of TDA 
2 One or a few strains were only inhibited by extracts 
 
Cell counts of V. anguillarum decreased rapidly within 2 hours when it was exposed to 
TDA-containing Roseobacter supernantat in a buffer system and no Vibrio were detected 
after 24 hours (Figure 11A). TDA also inhibited the growth of V. anguillarum in marine 
broth (Figure 11B). Similarly, the growth of P. mirabilis was immediately inhibited after 
addition of TDA, but no decrease in optical density was observed indicating that the 
bacteria were not lysed (Kintaka et al., 1984). The addition of TDA to P. mirabilis and E. 
coli did not cause lysis, but changed the morphology of the bacteria as they appeared 
swollen (Kintaka et al., 1984). Also the morphology of V. anguillarum changed when 
exposed to TDA containing supernatant. However, V. anguillarum cells appear to shrink 
when exposed to TDA (Hougaard et al., 2006).  
  
Figure 11: Survival in 
buffer (a) or growth in 
marine broth (b) of V. 
anguillarum when 
exposed to sterile filtered 
superantant from 
Rosobacter strain 27-4. 
(Bruhn et al., 2005b). 
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V. anguillarum did not become resistant to TDA even when continuously exposed to 
sublethal doses. Hence, production of TDA may have a persistent effect against this fish 
pathogen (Hougaard et al., 2006). 
  
The effect of TDA on a target bacterial cell may depend on the ionic strength of the 
medium. If V. anguillarum is inoculated in a 1:1 mixture of Roseobacter supernatant and 
marine broth, growth occurs after two days. In contrast, Vibrio does not grow if 
Roseobacter supernatant is mixed with a M9 salts medium with 3% NaCl, glucose and 
casamino acids (M9GC). The stability of TDA in these two systems is equal as measured 
in a well diffusion assay, however the target cell appears protected by marine broth.  
 
M9GC is high in phosphate buffer compared to marine broth and V. anguillarum is rapidly 
eliminated by TDA in a phosphate buffer, even thought the phosphate buffer by itself does 
not affect the V. anguillarum cells (Figure 11A). Phosphate buffers may inhibit enzymatic 
reactions and sequester divalent cations such as Ca2+ and Mg2+, and as these ions line the 
exterior of the cell, this may result in the enhance effect of TDA found in M9GC.  
 
3.2.3 Mode of action of TDA on prokaryotes 
 
TDA is hydrophilic in the marine environment (pKa 2.0 calculated using ACD v9.04 pKa 
package Advanced Chemistry Development) and will not be diffusible through the bacterial 
membrane. An active transport in and out of the cell is therefore necessary. The 
compound is active against both Gram-negative and Gram-positive bacteria indicating that 
the target is not membrane specific as seen for e.g. bacteriocines (Klaenhammer 1993). 
Furthermore, the cells do not appear to lyse indicating that the cell membrane is intact. 
The bacterial cells shrank or swelled indicating that the compound may affect the osmotic 
pressure within the cell. Both Gram-positive and Gram-negative bacteria have 
sophisticated systems to survive osmotic stress, and these systems allow the bacteria to 
accumulate or release specific solutes (Poolman and Glaasker 1998). The cell volume will 
change, if these systems are disrupted e.g. by blocking of the transport proteins or by 
allowing inorganic ions to travel unrestricted through the cell wall (Poolman and Glaasker 
1998). One can hypothesise that TDA react with ion channels or transporter proteins 
thereby destroying the ion gradient between the cytoplasm and the extracellular 
environment, eventually resulting in death of the bacteria. Genomic analysis of Silicibacter 
pomeroyi, a member of the Roseobacter clade, revealed an abundant number of transport 
proteins (Moran et al., 2004), which might give the roseobacters an advantage in resisting 
the effect of TDA as compared to non-Roseobacters. Identification of genes by DNA 
miroarray (Hansen et al., 2004) or arbitrarily PCR-amplified gene transcripts (Holmstrom 
28 
and Gram 2003), which are altered upon exposure to TDA, can be used to elucidate the 
mechanism of antibacterial action.  
 
3.3 Substrates for TDA 
 
3.3.1 Roseobacter in sulphur cycle  
 
Tropodithietic acid contains two sulfur atoms, which is interesting as members of the 
Roseobacter clade play an important role in the sulphur cycle in marine environment and 
have more specifically been linked to the degradation of dimethylsulfoniopropionate 
(DMSP) (Moran et al., 2003; Wagner-Döbler and Biebl 2006). DMSP is an abundant 
organic sulphur compound produced by marine algae and coastal vascular plants as an 
organic osmolyte (Ledyard et al., 1993). There are two pathways for the degradation of 
DMSP; the cleavage pathway and the demethylation/demethiolation pathway (Figure 12). 
DMSP is degraded by several groups of marine bacterial, however only members of the 
Roseobacter clade have both pathways (Moran et al., 2003). During cleavage, DMSP is 
split into dimethyl sulphide (DMS) and acrylate. DMS is volatile and readily fluxes to the 
atmosphere, in which it plays a role in the formation of cloud condensation nuclei and 
backscatter of solar radiation (Bates et al., 1987) (Figure 12). The demethylation/ 
demethiolation pathway result in the formation of methanethiol (MeSH) or by double 
demethylation 3-mercaptopropionate (MPA) (Moran et al., 2003). If DMSP is degraded by 
the demethylation/demethiolation pathway, the sulphur is most likely to stay in the ocean in 
contrast to the cleavage pathway, and the degradation of DMSP therefore has a climatic 
role.  
 
The TDA producer Silicibacter TM1040, can degrade DMSP and exhibit a positive 
chemotatic response towards DMSP, suggesting that this is an important compound for 
the bacterium (Miller et al., 2004; Miller and Belas 2004). Among four DMSP degrading 
Roseobacter strains, Silicibacter TM1040 was the only strain to produce detectable 
amount of antibacterial compound in supernatant (Miller and Belas  2004; Bruhn et al., 
2007). This strain also differed in its degradation of DMSP as only 3-
methylmercaptopropionate (MMPA) and no MeSH was detected. One can hypothesize 
that Silicibacter TM1040 is able to transfer sulphur from the DMSP degradation 
compounds to TDA and thereby use DMSP as sulphur source for TDA production. 
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Figure 12: Pathways of bacterial 
DMSP degradation in seawater. 
Roseobacter isolated are known 
to carry out both cleavage (to 
DMS) and demethylation / 
demethiolation to MeSH (Figure 
from Moran et al., (2003)).  
 
3.3.2 Sulphur source for TDA  
 
To elucidate the origin of the sulphur in TDA, Silicibacter TM1040 and Roseobacter 27-4 
were grown in Marine Basal Medium (MBM) (Baumann and Baumann 1981; Gonzalez et 
al., 1997), where sodium sulphate was replaced with sodium chloride. DMSP, MMPA, 
sulphate, amino acid, cysteine and methionine were added as sulphur source with glucose 
as carbon source. However, Roseobacter 27-4 was unable to produce TDA without 
addition of peptone and yeast extracts. 
 
Formation of pigment (OD398) correlated linearly with sulphate concentration and 
inhibition zones were measured in the well diffusion assay when OD398 was above 0.3 
(Table 5). This demonstrates that sulphate can be used as the sulphur source for TDA 
production. Sulphate is present in the marine environment at approx 28mM. Hence, this 
would be sufficient to act as TDA substrate (Geng et al., 2007). 
 
Pigment and inhibition zones were also detected when mixed amino acids and cysteine 
(as single amino acid) acted as substrates (Table 5). Silicibacter TM1040 did not produce 
TDA and pigment when DMSP, MMPA or methionine were added as the only sulphur 
30 
source. Cell densities of Silicibacter TM1040 increased in the presence of DMSP 
indicating that the DMSP was degraded during the experiments. The data do not 
demonstrate that DMSP, MMPA or methionine as sulphur sources cannot be used in the 
marine environment, but TDA was not measured in MBM with either of these compounds 
as a single sulphur source. 
 
Table 5: Log cell density, OD398 and inhibition zones from sterile supernatants in Silicibacter 
TM1040 cultures grown in MBM without sulphate, in the presence of varying sulphur sources 
(Geng et al., 2007). 
 
Sulphur source  Log10 CFU/ml OD398 Inhibition zone mm. 
No sulphate added 6.8 ± 0.1 0.00 ± 0.00 0 ± 0 
2 µM sulphate  6.6 ± 0.1 0.00 ± 0.00 0 ± 0 
20 µM sulphate 5.2 ± 0.3 0.02 ± 0.00 0 ± 0 
40 µM sulphate 5.7 ± 0.2 0.07 ± 0.03 0 ± 0 
80 µM sulphate 7.1 ± 0.2 0.11 ± 0.01 0 ± 0 
100 µM sulphate 7.9 ± 0.3 0.29 ± 0.03 17 ± 4 
200 µM sulphate 8.3 ± 0.3 0.38 ± 0.02 19 ± 1 
2 mM sulphate 8.4 ± 0.0 0.45 ± 0.06 21 ± 1 
22 mM sulphate 8.4 ± 0.0 0.49 ± 0.02 21 ± 0 
0,05% amino acid  7.4 ± 0.0 0.01 ± 0.00 0 ± 0 
0,5% amino acid 8.4 ± 0.1 0.05 ± 0.01 0 ± 0 
1% amino acid 8.1 ± 0.2 0.12 ± 0.01 12 ± 0 
2% amino acid 8.3 ± 0.1 0.23 ± 0.02 14 ± 1 
100 µM Methionine  5.2 ± 0.2 0.01 ± 0.00 0 ± 0 
1 mM Methionine 5.8 ± 1.1 0.02 ± 0.00 0 ± 0 
10 mM Methionine 7.6 ± 0.5 0.03 ± 0.00 0 ± 0 
100 µM Cysteine   8.1 ± 0.3 0.14 ± 0.04 13 ± 1 
1 mM Cysteine 8.5 ± 0.0 0.32 ± 0.04 19 ± 1 
10 mM Cysteine < 5.0 0.06 ± 0.01 0 ± 0 
100 µM DMSP 6.4 ± 0.1 0.00 ± 0.00 0 ± 0 
1 mM DMSP 7.4 ± 0.1 0.00 ± 0.00 0 ± 0 
10 mM DMSP 7.3 ± 0.2 0.01 ± 0.00 0 ± 0 
100 µM MMPA 6.4 ± 0.3 0.02 ± 0.00 0 ± 0 
1 mM MMPA 6.4 ± 0.2 0.00 ± 0.00 0 ± 0 
10 mM MMPA < 5.0 0.00 ± 0.00 0 ± 0 
 
Bacteria are only capable of incorporating sulphur from DMSP into protein if degrading 
DMSP to MeSH (Kiene et al., 1999). MeSH was not detected during degradation of DMSP 
by Silicibacter TM1040 (Miller and Belas 2004), however, the sulphur will mainly be 
incorporated into methionine if MeSH is produced under other environmental conditions 
(Kiene et al., 1999). Silicibacter TM1040 was not capable of utilizing methionine as a 
single sulphur source to form TDA, indicating that sulphur from DMSP cannot be 
incorporated into TDA. 
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Pigment and antibacterial compound were not detected if Silicibacter TM1040 was grown 
in MBM in the presence of 200µM sulphate without glucose. The low cell density at about 
7.0 log CFU/ml may partly explain the absence of pigment and inhibition zones, however 
pigment was measured at the same cell density in the presence of glucose, suggesting 
that TDA was produced. Glucose may therefore acts as carbon source for the formation of 
TDA in the absence of amino acids, as inhibition zones and pigment were detected when 
Silicibacter TM1040 was grown with mixed amino acid in the absence of glucose. No 
pigment and inhibition zone were seen when varying concentrations of DMSP were added 
to samples containing 200µM sulphate, indicating that DMSP cannot be utilized as the 
carbon source for TDA. 
 
3.4 Synthesis and regulation of TDA 
 
Genes involved in synthesis of TDA were identified via Tn5 based transposon insertion 
library in both Roseobacter 27-4 and Silicibacter TM1040. Mutants devoid of antibacterial 
activity were selected for analysis, and all mutants devoid of antibacterial activity were 
non-pigmented, indicating a strong correlation between pigment and formation of 
antibacterial compounds (Brinkhoff et al., 2004; Bruhn et al., 2005b). The full genome of 
Silicibacter TM1040 has been sequenced, hence the analysis was conducted in this 
bacterium. The locations of the transposons in the TDA negative mutants in the Silicibacter 
TM1040 genome are shown in Figure 13. Some of the inserts were in genes located on a 
cryptic plasmid that has not been sequenced as part of the genome. 
 
 
Figure 13: Locations of the transposons in the Silicibacter TM1040 genome. Genes are marked 
depending on function. Numbers refer to the mutant number (Geng et al., 2007).   
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A biosynthesis pathway and the regulation of TDA in Silicibacter TM1040 were suggested 
by combining information on the genes identified (Geng et al., 2007). All genes identified in 
Roseobacter 27-4 corresponded to genes found in Silicibacter TM1040 suggesting that the 
biosynthetic pathway and regulation functions are similar in this bacterium (Geng et al., 
2007). 
 
3.4.1 Biosynthesis of TDA 
 
During biosynthesis of antibacterial compounds, organisms often use parts of pathways for 
primary metabolites (Martin and Demain 1980). This also seems to be true for TDA, as 
approx. 65% of the genes identified in non-TDA producing mutants of Silicibacter TM1040 
were house keeping genes. Coenzyme A (CoA) and the shikimate pathway were essential 
in the biosynthesis and these two where combined via the phenylacetate-CoA ligase 
(PaaK) with phenylacetate as substrate from the shikimate pathway (Figure 14).  
 
 
Figure 14: Suggested biosynthesis pathway of TDA in Silicibacter TM1040 (Geng et al., 2007).  
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The shikimate pathway is an essential metabolic route by which bacteria synthesize the 
aromatic amino acids phenylalanine, tyrosine and tryptophan as well as a number of other 
aromatic compounds (Floss 1997). Substrates to the shikimate pathway originate from the 
glycolysis, which agrees with that glucose may act at carbon source for TDA.  By labelling 
glucose Cace et al., (1992) demonstrated that the shikimate pathway is part of the 
synthesis of TDA in Pseudomonas CB-104. The phenylacetate can also originate directly 
from the amino acid phenylalanine (Cane et al., 1992) and this may explain why growth 
substrates supplemented with L-phenyalanine resulted in a more pure TDA with less by-
products (Heidorn 2002).  
 
The final five steps in the synthesis are conducted by the genes tdaB-tdaF. These genes 
are regulated by tdaA, and tdaA-tdaF is located in an operon on a cryptic plasmid (Figure 
13 and 14) (Geng et al., 2007). The location of these important genes on a plasmid 
indicate that the loss of antagonistic activity found in several stable spontaneous mutants 
(Bruhn et al., 2007), may be a result of the loss of this plasmid. Brinkhoff et al., (2004) 
found stable spontaneous mutants of R. inhibens T5 lacking the ability to produce TDA. 
Furthermore one could suggest that the transfer of such a plasmid could give other 
Roseobacter the ability to produce TDA.  
 
Cace et al., (1992) did not provide experimental data demonstrating how the two sulphur 
atoms are added to TDA, and our genetic analysis did not reveal the source of sulphur. 
However, we suggested that cysteine or its intermediates may be the source (Geng et al., 
2007). Cysteine acts as sulphur source for TDA. Also TDA is produced when sulphate is 
added, but this is probably because sulphate can be assimilated into cysteine by the 
reductive sulphur metabolism (Truper 1975; Leustek et al., 2000). The reductive sulphur 
metabolism was disrupted by a transposon in the cysI (Sulfite reductase) gene. This 
mutant was unable to produce TDA in medium containing sulphate or methionine as the 
only sulphur source, however, when adding exogenous cysteine the mutants were able to 
produce TDA. This demonstrates that cysteine is an important substrate for TDA and 
indicates that methionine cannot be converted to cysteine. However, this doesent 
demonstrate that methionine cannot act as substrate in the natural habitat. 
 
3.4.2 Regulation of TDA production 
 
The genetic analysis indicate that TDA loss of function mutations affected genes encoding 
regulatory proteins and strongly suggests that TDA synthesis is regulated at the level of 
transcription (Geng et al., 2007). The genetic analysis revealed that tranposons hit 
homologs of regulatory genes such as rpoE, rsbU and hrcA, these genes are part of a 
stress response within several bacteria (Raina et al., 1995; Chen et al., 2003; Susin et al., 
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2004). Stress often induces antibiotic production in bacteria (Marahiel et al., 1993; 
Sarniguet et al., 1995; Haas and Keel 2003). The regulation of antibiotic in several Bacillus 
spp is an interaction of diverse factors (e.g. nutritional stress), which also control other 
stationary phase induced processes in Bacillus spp e.g. sporulation (Marahiel et al., 1993). 
High levels of antibiotics are usually only produced in the stationery phase when antibiotic 
producing bacteria are grown in nutrient rich media (Martin and Demain 1980). This is also 
the case for Silicibacter TM1040 (Bruhn et al., 2007). 
 
If one believes that antibacterial compounds are a competitive phenotype produced to 
inhibit other organisms, it should be absent in the exponential growth phase where rapid 
growth is the best way to compete. In some experiments, growth rate is a major parameter 
controlling the long term bacterial population density (Grossart et al., 2003). The absence 
of antibacterial compound in the exponential phase may also be explained by the bacteria 
themselves being more sensitive in the exponential phase. Thus, they might be inhibited 
by their own production of antibacterial compounds (Martin and Demain 1980).  
 
LysR-type family represents a common class of transcriptional regulatory proteins and 
members function as both activators and repressors of a wide variety of target genes e.g. 
virulence genes (Kovacikova and Skorupski 2002; Heroven and Dersch 2006), genes 
encoding antibacterial and antifungal compounds (Naas et al., 1995; Silby et al., 2005) and 
genes involved in sulphur utilization (Jovanovic et al., 2003). A LysR-type family 
transcriptional regulator homolog was also hit by a transposon resulting in loss of TDA 
production, indicating that this is part of the regulation of TDA in Silicibacter TM1040 
(Geng et al., 2007).  
 
Antifungal activity is regulated by a LysR-type regulator in Pseudomonas aureofaciens and 
a mutant in the LysR regulatory gene does not produce antifungal activity, but the mutant 
grew to higher numbers in the stationary phase as compared to the wild type (Silby et al., 
2005). Similar findings were seen for both Roseobacter 27-4 and Silicibacter TM1040 as 
antibacterial activity negative mutants grow to about ½ log unit higher cell density in the 
stationary phase (unpublished results Bruhn). As production of an antibacterial compound 
may be a “burden” for the bacteria, it must provide the producer cell with an advantage, 
otherwise the negative mutants would take over and become dominant.  
 
Production of antibacterial compound may give the bacteria other advantages than just 
inhibiting other bacteria, as these compounds may also act as signal compounds (Yan et 
al., 2003; Mai-Prochnow et al., 2006). The antibacterial compound in a Bacillus strain 
serves as a signal, which induce planktonically grown cells to behave as if they were in a 
biofilm (Yan et al., 2003). An antibacterial and autocidal protein produced by 
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Pseudoalteromonas tunicate was suggested to confer an ecological advantage to the 
bacteria dispersed from biofilms. These cells were metabolically highly active in 
phenotypes suggested to be important for colonization of new surfaces (Mai-Prochnow et 
al., 2006). 
 
3.5 Conclusions from chapter 3 
 
The antibacterial compound produced by Roseobacter 24-7 and some other members of 
the Roseobacter clade is tropodithietic acid (TDA). TDA affects both eukaryotic and 
prokaryotic cells, but eukaryotes seem less sensitive as compared to prokaryotes. TDA 
affected Roseobacter and a few other strains to a lesser degree than a range of other 
tested strains, hence production of TDA may give members of the Roseobacter clade a 
selective advantage during interaction.  
 
It was suggested that DMSP might act as sulphur source for TDA, however it was not 
possible to demonstrate this. It was demonstrated that both sulphate and cysteine act as 
sulphur source for TDA. Analysis of mutants defective in production of TDA indicated that 
stress factors are important in the regulation of TDA in Silicibacter TM1040. Production of 
antibacterial compounds reduces the maximum cell density of the population, hence, 
bacterial strains may regulate their production of antibacterial compound under different 
growth condition to optimize their growth. One may speculate that production of 
antibacterial compound is only beneficial under certain growth conditions. 
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4 Factors affecting production of antibacterial compounds and 
biofilm in marine bacteria 
 
It is hypothesized in this thesis that the Roseobacter antibacterial compound, TDA is an 
important mechanism underlying its probiotic effect. In order to facilitate and optimize the 
use of Roseobacter strains as probiotic bacteria it is therefore necessary to understand 
how growth conditions influence the production of TDA. It is furthermore speculated that 
the biofilm mode of growth could facilitate antagonism and that the probiont may be added 
as a colonizer of the aquaculture environment. If Roseobacter strains are to be 
administered to tank walls in rearing facilities, phenotypes important for attachment also 
have to be elucidated. Roseobacters are, however, not the only group of marine bacteria 
with antagonistic effects against other bacteria and the present chapter introduce several 
marine bacteria that produce antibacterial compounds and discuss how environmental 
factors can influence the production.  
 
4.1 Antibacterial compounds produced by marine bacteria 
 
Already in 1889, marine bacteria with inhibitory effects against other bacteria were 
described (Giaxa 1889), and subsequent Rosenfeld and Zobell (1947) described antibiotic 
producing marine microorganisms. Antibacterial compounds are produced by several 
marine bacterial groups including Alteromonas, Pseudoalteromonas, Pseudomonas, Vibrio 
all belonging to the γ-Proteobacteria, and also members of the Roseobacter clade Bacillus 
spp and Choromobacterium spp produce antibacterial compounds (Ivanova et al., 1998; 
Jensen and Fenical 2000; Imada et al., 2002; Isnansetyo and Kamei 2003; Bruhn et al., 
2005b). Pseudomonas spp. and/or Alteromonas spp. are often most abundant among 
culturable marine bacteria with antibacterial activity (Lemos et al., 1985; Nair and Simidu 
1987; Jayanth et al., 2002), however a range of other culturable bacteria may also produce 
antibacterial compounds (Grossart et al., 2004; Anand et al., 2006). 
 
Many different antibacterial compounds have been isolated from marine bacteria (Table 6). 
Most of these compounds are low molecular weight, thermolabile compounds. They are 
not affected by proteolytic enzymes indicating that they are not proteins (Lovell 1966; 
Burkhold et al., 1966; Lemos et al., 1985; Jensen and Fenical 2000; Nakashima et al., 
2005; Bruhn et al., 2005b; Saha et al., 2006), however, also antibacterial proteins are 
produced by marine bacteria (Barja et al., 1989; James et al., 1996). There is variation in 
the antibacterial spectrum of these antibacterial compounds, as some have a broad 
spectrum and others are more specific (Table 6) (Lemos et al., 1985; Nakashima et al., 
2005; Anand et al., 2006; Bhattarai et al., 2006; Saha et al., 2006).  
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Table 6:  Type and spectrum of antibacterial compound produced be marine bacteria. 
  
Marine Bacteria Antibacterial 
compound(s) 
Active against Reference 
Actinobacterium  Non-proteinaceous 
(low molecular weight 
compound)  
E. coli; Salmonella enterica; S. 
aureus; Klebsiella pneumoniae 
Saha et al., 2006 
    
Alteromonas spp. Glycoprotein Several Gram-positive and 
Gram-negative strains, did not 
inhibit Enterobacter spp; 
Bacillus spp and C. albicans 
Barja et al., 1989 
    
Bacillus cereus  Thiocillin (peptide) Gram-positive bacteria Nagai et al., 2003 
    
Hahella spp. Prodigiosin (low 
molecular weight 
compound) 
Gram-positive bacteria 2005 Nakashima et 
al., 2005 
    
Halomonas spp. Aminophenoxaxinones
(low molecular weight 
compounds) 
Escherichia coli; Bacillus 
subtilis; S. aureus; C. albicans  
Bitzer et al., 2006 
    
Pseudoalteromonas 
spp  
Korormicin (low 
molecular weight 
compound)  
Salinivibrio costicola and 
Pseudoalteromonas 
haloplanktis did not inhibit E. 
coli 
Yoshikawa et al., 
2003 
    
Pseudoalteromonas 
tunicata 
a 190-kDa protein E. coli; Bacillus spp; 
Pseudomonas spp; Proteus 
mirabilis did not inhibit Serratia 
liquefaciens  
James et al., 1996  
    
Pseudomonas 
bromoutilis 
Pentabromopseudiline 
(low molecular weight 
compound)  
Staphylococcus spp; 
Streptococcus spp; 
Mycobacterium tuberculosis; 
C. albicans 
Lovell 1966; 
Burkhold et al., 
1966 
    
Roseobacter spp. Thiodithietic acid (low 
molecular weight 
compound) 
see Table 4 Brinkhoff et al., 
2004; Bruhn et al., 
2005b 
 
TDA produced by Roseobacter strains has a broad antibacterial spectrum, as all tested 
bacteria are sensitive to the compound (Table 4). Bruhn et al., (2007) stated that members 
of the Roseobacter clade are less sensitive compared to non-Roseobacter. However the 
sensitivity to TDA was only tested against culturable members and it can therefore not be 
concluded that the members of the Roseobacter clade in general are less sensitivity to 
TDA, as many members are not culturable (Buchan et al., 2005). 
 
4.1.1 Environmental conditions affecting production of antibacterial compounds 
 
Environmental conditions affect production of antibacterial compounds in several marine 
38 
bacteria (Sugita et al., 1997; Ivanova et al., 1998; Marwick et al., 1999; Yan et al., 2002; 
Yan et al., 2003; Bruhn et al., 2005b; Bitzer et al., 2006). E.g. biofilm formation affect 
production in a Bacillus licheniformis, concentration of marine salt affects production in a 
Vibrio strain and presence of oxygen affects the production in a Bacillus brevis. The 
production of TDA by Roseobacter strains is influenced by several factors including 
temperature, marine salts and physical growth conditions.  
 
Coastal bacteria that produce antibacterial compounds are often pigmented (Nair and 
Simidu 1987; Jayanth et al., 2002) and in some bacteria, the pigment is the antibacterial 
compound (Duran and Menck 2001; Nakamura et al., 2002). A strong correlation is found 
between a brown/black pigment and antibacterial activity for several TDA producing 
Roseobacter strains (Figure 15) (Brinkhoff et al., 2004; Bruhn et al., 2005b; Bruhn et al., 
2007), which may indicate that the pigment has an antibacterial activity.  
 
Figure 15: Influence of culture conditions on 
the growth, production of pigment, and 
antibacterial activity of Roseobacter 27-4 and 
Silicibacter TM1040 in MB at 25°C. A) 
Growth measured by plate counts: □ shaken 
culture of Roseobacter 27-4, ○ static culture 
of Roseobacter 27-4, ▽ shaken culture of 
Silicibacter TM1040, △ static culture of 
Silicibacter TM1040. B) Pigment formation, 
as measured by absorbance at OD398. C) 
Antibacterial activity represented by the zone 
of inhibition (in mm), as determined using the 
well diffusion assay with V. anguillarum 
(Bruhn et al., 2007). 
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Pigmented compounds can indeed have active antibacterial activity e.g. violacein 
produced by Chromobacterium violaceum (Duran and Menck 2001; Nakamura et al., 
2002). However the brown pigment produced by Roseobacter strains was not the 
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antibacterial compound (Bruhn et al., 2005b; Professor Dr. A. Zeeck personal 
communication), as the pigment was retained on the purification column, whereas the 
active compound was not.  
 
The pigment production and TDA antibacterial activity were absent or reduced under 
shaken growth conditions in Roseobacter 27-4 and Silicibacter TM1040 (Figure 15) (Bruhn 
et al., 2005b; Bruhn et al., 2007). Also shaken growth conditions affected both production 
of antibacterial activity and pigment in a B. licheniformis as none of these were produced 
under shaken growth conditions (Yan et al., 2002; Yan et al., 2003).   
 
The surface volume ratio affected the production of pigment and TDA in Roseobacter 27-4 
(Bruhn et al., 2005b) and pigment formation always started at the surface media interface 
(Figure 16), which suggests that the atmosphere may affect the production.  
 
Figure 16: Production of pigment by 
Roseobacter 27-4 depending on the 
surface volume-ratio of marine broth. 
Biofilm and pigment formation was 
visible at the air-media interface after a 
few days incubation at 25°C (Bruhn et 
al., 2005b). 
    
 
Atmosphere can be important for production and stability of antibacterial compounds. The 
presence of oxygen inhibits the production and accelerated the breakdown of the 
antibacterial compound gramicidin in B. brevis (Friebel and Demain 1977), but had no 
effect on production of pigment and antibacterial compound in Roseobacter 27-4 (Table 7). 
Growth of Roseobacter 27-4 stopped when the atmosphere was changed using 
carbondioxide. 
 
Table 7: Production of pigment by Roseobacter 27-4 when grown under different atmospheres 
(Bruhn, unpublished results). 
 
% composition 
Air, atmosphere Oxygen Nitrogen Carbondioxide  
Pigment and 
TDA production 
56 44   +1
40 60   + 
15  85  + 
10  90  + 
4  96  + 
80   20 - 
50   50 - 
1+: Similar levels of pigment and antibacterial activity as compared to normal atmosphere 
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Several members of the Roseobacter clade produce pigments to utilize light (Wagner-
Döbler and Biebl 2006) and accumulation of the phototynthetic pigments in Roseobacter 
denitrificans occurred only in darkness (Takamiya et al., 1992). It is not known if these 
photosynthetic pigments have antibacterial activity, but we investigated if light affected the 
production of pigment in Roseobacter 27-4. Results were inconclusive as light appeared to 
affect pigmentation negatively when the organism was grown on agar-plates, but these 
data could not be reproduced in liquid medium (unpublished results by Bruhn). 
 
Marine salt influences the production of antibacterial compounds in marine bacteria as a 
higher degree of antibacterial activity was observed in a streak test on agar plates when 
using 3.5% marine salts in the growth substrate compared to 1% (Strahl et al., 2002). If the 
influence of marine salt is due to enhanced production of antibacterial compound or higher 
sensitivity by the target bacteria is unknown. The concentration of marine salts affected 
Vibrio NM10 production of antibacterial compound, where the highest activity was seen 
when adding 50% seawater to the media (Sugita et al., 1997). Sterile filtration of marine 
broth decreased the production of TDA in Roseobacter 27-4, suggesting that insoluble 
salts are important for TDA production (Bruhn et al., 2005b). Several of the marine salts 
may be important for instance iron, which induced the production of antibacterial 
compound in B. licheniformis and Pseudomonas syringae (Palmer and Bender 1993; Yan 
et al., 2003). The NaCl concentration may also affect the antibacterial activity, as 
increased NaCl concentrations above 1% caused a decrease in antibacterial activity in 
Pseudomonas I-2 and P. syringae (Palmer and Bender 1993; Chythanya et al., 2002).   
 
Growth substrates may also affect production of antibacterial compounds by marine 
bacteria as using a carbon sources which is slowly utilized, gives an improved antibiotic 
yield as compared to glucose (Martin and Demain 1980; Marwick et al., 1999). Specific 
carbon and nitrogen sources may also have an influence on production of antibacterial 
compounds. E.g. only with anthranilic acid, as both carbon and nitrogen source, did 
Halomonas spp produce five antibacterial aminophenoxazinones (Bitzer et al., 2006). 
Furthermore, when utilizing cysteine as a single amino acid source Silicibacter TM1040 
produced TDA, however in the presence of methionine as single amino acid source no 
TDA was produced (Geng et al., 2007).  
 
Both the general microbiota of sponge surface associated bacteria and bacteria with 
antibacterial activity change over the year, which may be a temperature effect (Thakur et 
al., 2004). Temperature can also influence production of antibacterial compounds in 
several marine bacteria. Production of TDA in Roseobacter 27-4 decreased at 30°C as 
compared to temperatures at 20 or 25°C (Bruhn et al., 2005b). Similarly, the antibacterial 
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activity in Vibrio strain NM10 and P. syringae was decreased at 30°C as compared to 
lower growth temperatures, however in Pseudomonas I-2 the highest activity was seen at 
30 and 37°C (Palmer and Bender 1993; Sugita et al., 1997; Chythanya et al., 2002).  
 
Antibacterial activity was only detected in late exponential and stationary phases for 
several marine probiotic bacteria (Figure 15) (Chythanya et al., 2002; Jayaprakash et al., 
2005; Vijayan et al., 2006; Bruhn et al., 2007). This may be due to detection limits of the 
assay or indeed that the compound is only produced in the stationary phase. Brinkhoff et 
al., (2004) stated that TDA was produced by R. inhibens T5 in the complete growth phase, 
but based on the presented data they only documented that TDA was produced in the late 
exponential and stationary phase.  
 
4.1.2 Quorum sensing control of antibacterial compounds 
 
The detection of TDA in late exponential/stationary phase could lead one to speculate that 
the compound is quorum sensing regulated. The production of antibacterial compounds 
may be controlled in a quorum dependent manner (Bainton et al., 1992; Throp et al., 1995; 
Wood et al., 1997) e.g. the probiotic bacteria P. aureofaciens, which is used to protect 
wheat against filamentous fungi, regulate the expression of three antibiotics in situ on plant 
roots by using a quorum sensing system (Wood et al., 1997). In a collection of 13 
members of the Roseobacter clade, AHLs were only detected in strains that produced 
antibacterial activity (Bruhn et al., 2007). But there was no direct link between AHL 
production and antibacterial activity as antibacterial activity was also detected in strains 
that did not produce AHLs e.g. Silicibacter TM1040. Quorum sensing signal compounds 
are produced by several members of the Roseobacter clade (Gram et al., 2002; Wagner-
Döbler et al., 2004; Bruhn et al., 2005b). In Roseobacter 27-4 N-(3-hydroxydecanoyl)-L-
homoserine lactone is produced, which is also detected in the TDA producing R. inhibens 
T5 (Wagner-Döbler et al., 2004; Bruhn et al., 2005b). Quorum sensing regulation of 
antibacterial compounds could be a way for the bacteria to optimize their competitive 
ability. At low cell densities there may be less need for competition, whereas at higher cell 
densities it may be beneficial to produce antibacterial compounds when the nutrient levels 
are decreasing. To date no studies have demonstrated quorum sensing controlled 
phenotypes in members of the Roseobacter clade. 
 
4.2 Cell morphology and biofilm formation of Roseobacter 
 
An intriguing characteristic of several Roseobacters is their growth as starshaped rosettes 
(Figure 17). Rosette forming bacteria are often found in the marine environment and 
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especially members of the Roseobacter clade form rosettes (Leifson et al., 1964; Ruger 
and Hofle 1992; Gonzalez et al., 1997; Uchino et al., 1998; Labrenz et al., 1998; Pukall et 
al., 1999; Gonzalez et al., 2003; Pladdies et al., 2004; Larimer et al., 2004; Amaro et al., 
2005; Bruhn et al., 2005b; Jansen 2006; Bruhn et al., 2007), however, it is not a specific 
marine phenomena as also soil bacteria produce rosettes (Whang and Hattori 1988). 
 
Figure 17: Scanning electron micrographs 
of Roseobacter strain 27-4 grown in Marine 
Broth under static conditions. Standard 
fixation and dehydration procedure was 
used (Bruhn et al., 2005b). 
 
 
One can speculate on which advantages the bacteria obtain by forming this structure, and 
it can be suggested that the rosette formation reduce grazing of the bacteria. Size of 
bacteria is suggested as a defence mechanism for bacteria to avoid grazing (Lebaron et 
al., 1999). Optimal bacterial grazing for Spumella guttula occurs at bacterial sizes between 
0.8 to 1.5 µm and grazing is rapidly decreased when the size of the bacteria exceeds 1.5 
µm (Kinner et al., 1998). When forming the rosette structure the size of the aggregates is 
about 5 µm in diameter (Figure 17) (Bruhn et al., 2005b), which can make them 
unattractive for grazing. Members of the Roseobacter clade have been detected before 
and after grazing, while others were not detected after grazing indicating that this group 
has a defence mechanism, however it is unknown if these isolates formed rosettes 
(Lebaron et al., 1999).   
 
The mechanism of rosette formation are only partially described, but may be linked to the 
flagella system of bacteria (Leifson et al., 1964). Several strains of motile marine bacteria 
are capable of forming rosettes (Leifson et al., 1964). Furthermore, Bruhn et al., (2007) 
found a correlation between rosette formation and motility as all rosette forming strains 
were motile and only one strain was motile without forming rosettes. The flagella were 
important for the rosette formation in strains belonging to Caulobacter as the cell attached 
to each other by using the flagella (Leifson et al., 1964). The rosette formation in 
Agrobacterium luteum was due to polar fibrils, which are spread around the rosette shaped 
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aggregate. These fibrils were up to 10.5 µm long (Ahrens et al., 1968). Also the cells of 
Roseobacter 27-4 attached to each other by a fibril (Figure 17), however, the cells seemed 
to divide into the rosette formation rather than single cells attaching to each other. No 
flagella are observed on cells in the rosette formation, but during planktonic growth both 
Roseobacter 27-4 and Silicibacter TM1040 are highly motile. It can be speculated that the 
flagella system in bacteria is part of the formation of the fibril by which the cells are 
attached. This may explain the correlation between rosette formation and motility.    
 
Growth conditions affected the formation of rosettes in Roseobacter 27-4 as static grown 
cultures are dominated by rosette forming aggregates in contrast to shaken cultures, which 
mostly consist of motile planktonic cells (Figure 18). Also the TDA producing R. inhibens 
T5 formed similar rosette structure in static culture (Bruhn personal observation). 
Silicibacter TM1040 also forms TDA, pigment and rosettes when grown as a shaken 
culture, albeit at a much lower level than in stagnant cultures (Figure 15 and 18). However 
the rosette formation is not directly correlated to TDA production as the non-pigmented 
TDA negative spontaneously mutants in Silicibacter TM1040 still form rosettes (Bruhn et 
al., 2007). 
 
 Shaken Static 
Silicibacter TM1040 
Roseobacter 27-4 
Figure 18: Silicibacter TM1040 and Roseobacter strain 27-4 grown in Marine Broth at 20ºC 
under static and aerated conditions. Pictures are from phase contrast microscope at x 1000 
magnification (Bruhn et al., 2007). 
 
Pladdies et al., (2004) investigated rosette forming bacteria in the neuston, which are 
bacteria which float on or drift immediately under the water surface, and found three 
different rosette morphotypes. They believed that these morphotypes enable the bacteria 
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to grow at the air-water interface, which is also where the highest concentration of rosettes 
are found in cultures of Roseobacter (Bruhn et al., 2005b; Bruhn et al., 2007). 
Furthermore, members of the Roseobacter clade are most often found in the upper mixed 
layer in the marine environment (Buchan et al., 2005).  
 
Roseobacter are the most rapid colonizer of surfaces in the coastal environments (Dang 
and Lovell 2000; Dang and Lovell 2002). Bruhn et al., (2007) believed that this high 
attachment capability is caused by the ability to form rosettes, as Roseobacter strains with 
a pronounced rosette formation under static growth conditions were most affective in 
attachment to surfaces and producing a biofilm at the air liquid interface (Figure 19) (Bruhn 
et al., 2006; Bruhn et al., 2007).  
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Figure 19: Attachment of Roseobacter clade bacteria from static (Dotted bars) or shaken (Filled 
bars) cultures to glass cover slides measured by crystal violet at OD590. Sulfitobacter EE36, 
Sulfitobacter 1921, Silicibacter TM1040, Roseobacter TM1039 and Roseobacter 27-4 all had a 
pronounced rosette formation under static growth conditions (Bruhn et al., 2007).  
 
The biofilm formed at the air liquid interface contained rosettes attached to each other 
(Bruhn et al., 2005b). The slime layer covering the rosette seen in Figure 20 may be one 
reason for rosette-rosette attachment. This slime may be exopolysaccharide (ESP), which 
is an important phenotype during attachment and formation of biofilm (Pratt and Kolter 
1999; Jefferson 2004) and ESP is produced by members of the Roseobacter clade (Kwon 
et al., 2002). We have, however, not yet investigated the EPS production in Roseobacter. 
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Figure 20: Scanning electron micrographs 
of Roseobacter strain 27-4 grown in Marine 
Broth under stagnant conditions. Cells were 
only exposed to osmium vapour and 
subsequently coated with gold-palladium 
(Bruhn et al., 2005b). 
 
 
The rosette structure is also correlated to the ability of Roseobacter 27-4 to form biofilm on 
inert surfaces, as inoculating static cultures into a flow chamber system resulted in a three-
dimensionally biofilm (Figure 21) (Bruhn et al., 2006). In contrast, when inoculating of a 
shaken culture no three-dimensionally biofilm was observed, even though attached 
planktonic cells were seen.  
 
Attachment and biofilm formation of Roseobacter 27-4 Culture conditions 
Day 0 Day 3 Day 6 
Shaken culture 
   
    
Static culture 
   
Figure 21: Comparison of biofilm formation of Roseobacter 27-4 inoculated from a shaken or static 
preculture. Pictures from day zero and day three are from phase contrast microscope at x 1000 
magnification, pictures from day six are from confocal laser scanning microscopy (Bruhn et al., 
2006) 
 
The correlation between rosette and biofilm formation may be a further link to a grazing 
defence as formation of biofilms is a protective agent against grazing for e.g. Vibrio 
cholerae (Matz et al., 2005). During biofilm formation V. cholerae secrete an antiprotozoal 
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factor, which is part of the defence against grazing. TDA also has an antiprotozoal activity 
(Tsubotani et al., 1984) and the production of TDA is most pronounced under conditions 
that facilitate biofilm and rosette formation. The combination of forming both rosette and 
biofilm and producing TDA may be optimal in avording grazing. 
 
4.3 Conclusions from chapter 4 
 
Production of antibacterial compound is widespread among marine bacteria. Most of these 
compounds are low molecular weight non-proteinaceous substrates, however, also 
proteinaceous compounds are found. The ability to produce antibacterial compounds is 
often associated with the ability to produce pigments. The production of antibacterial 
compounds is in several marine bacteria affected by growth conditions such as 
concentration of marine salts, atmosphere, available nutrients and physical growth 
conditions. The marine environment is however not unique in containing bacteria with 
antibacterial activity as e.g. soil also contains antibacterial producing strains especially 
Bacillus spp. and Pseudomonas spp. The compounds in these bacteria are affected in a 
similar manner as for the marine bacteria (Duffy and Defago 1999; Raaijmakers et al., 
2002; Haas and Keel 2003; Urdaci and Pinchuk 2004).  
 
During growth conditions that enhanced production of antibacterial compounds a rosette 
shaped aggregate was dominating in Roseobacter cultures. This rosette shape structure is 
correlated to biofilm formation, which could indicate that a biofilm mode of growth facilitate 
antagonism of Roseobacter. Correlations between biofilm formation and antibacterial 
compound can also be found in other marine bacteria (Yan et al., 2002; Yan et al., 2003), 
hence one may suggest that these phenotypes could be important for colonisation of the 
marine environment. Rosette forming bacteria are found both in marine environment as 
well as in other environments. However, most reports of rosette forming bacteria deal with 
members of the Roseobacter clade. The bacteria may have different advantages by 
producing the rosette shape e.g. it may reduce grazing.  
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5 Habitats of Roseobacter in the marine environment  
 
It is likely that phenotypes such as ability to attach, form biofilms and produce antibacterial 
compounds are important for members of the Roseobacter clade in their natural habitat. 
This chapter will describe the habitats of Roseobacter in the marine environment as the 
Roseobacter clade is exclusively marine or hypersaline (Buchan et al., 2005).   
 
The marine environment contains approximately 106 cells/ml of surface seawater and the 
diversity of bacteria strains in the marine environment is enormous, however the majority 
(80%) of marine bacteria fall into only nine major phylogenetic groups (Figure 22). These 
groups include the SAR11 (Pelagibacter ubique), which is the most abundant bacteria in 
the marine environment and the Roseobacter clade, both members of the α-
proteobacterial group (Giovannoni and Rappe 2000; Morris et al., 2002; Giovannoni and 
Stingl 2005). 
 
 
Figure 22: Frequency of the most 
common bacterioplankton SSU rRNA 
gene clusters. Frequencies were 
determined by dividing the number of 
clones from a particular gene cluster 
by the total number of clones in the 
data set. Clones from marine snow 
and sediments, and Archaea, were not 
included in the data set (Figure from 
Giovannoni and Rappe 2000). 
 
It is debated if marine bacterioplankton are cosmopolitans in other words if all bacteria are 
everywhere and if it is just a question of detecting them or if real distribution are found in 
the marine environment (Pedros-Alio 2006). It seems that some marine bacterioplankton 
are cosmopolitans e.g. members of the SAR11 (Pelagibacter ubique), one member of the 
Roseobacter clade and a member of the SAR86 clade, where as other are restricted to 
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some regions (Pommier et al., 2005). Distribution is also found within the Roseobacter 
clade as a newly discovered cluster affiliated to the Roseobacter clade is only found in the 
arctic and southern oceans (Selje et al., 2004).  
  
Our understanding of the marine ecology is to some degree based on culturable marine 
bacteria, however only 0.1% to 6% of marine bacteria are so far found to be culturable 
(Lanoil et al., 2000; Bernard et al., 2000; Simu et al., 2005). Until recently, only the 
Roseobacter clade and the marine Picophytoplankton had members that were culturable, 
among the nine most abundant bacterialplankton groups, giving these two groups a central 
role when investigating marine ecology, however the first culturable member Pelagibacter 
ubique of SAR11 is now found (Giovannoni et al., 2005). Most culturable bacteria in the 
marine environment belong to the γ-Proteobacteria (Giovannoni and Rappe 2000). 
Alteromonas spp and Vibrio spp were found to be the most abundant among culturable 
strains isolated from the Sargasso Sea (Lanoil et al., 2000), and members of the 
Roseobacter clade only accounted for a small proportion. However, members of the 
Roseobacter clade dominated among culturable bacteria in the Baltic and Skagerrak Sea 
(Simu et al., 2005). This may be explained by that members of the Roseobacter clade 
were the most active in the North Sea to incorporate glucose, which is typically the most 
abundant free neutral aldose in seawater (Alonso and Pernthaler 2006).  
 
Members of the Roseobacter clade are mostly non-culturable and 68% of the members 
have presently no close relatives in cultures, however, this clade is still one of the most 
accessible of the major marine taxa. Insights gained form the culturable members of the 
Roseobacter clade will continue as the basis of testable hypotheses for illuminating the 
ecological roles of this group (Buchan et al., 2005).  
 
The representation of Roseobacter in upper mixed layer of seawater ranges from not 
detected and up to 27%. The highest density is found in costal environment and the 
population decrease with depth (Buchan et al., 2005). Members of the Roseobacter clade 
are often the most abundant in bacterial communities associated with marine algae, 
including phytoplankton blooms and algal cultures (Table 8). Harmful algal booms are 
increasing in frequency along the coastal regions around the world. The algae are typically 
colonized by bacterial communities, which may play a role in the development of the algal 
bloom. Members of the Roseobacter clade are known to interact with algae, and enhanced 
growth of the algal is found in the present of some Roseobacter strains (Alavi et al., 2001; 
Alavi 2004). Other Roseobacter strains produce algal lytic compounds (Amaro et al., 2005) 
and also TDA can be toxic to algal (Kawano et al., 1997; Liang 2003).  
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Table 8: Bacterial groups dominating in association with phytoplankton, estimated by numbers of sequences or culturable bacteria. 
 
Phytoplankton Dominating among isolated sequences or culturable 
bacteria 
Detection method(s)  Isolated from  Reference 
Alexandrium spp. 46% Roseobacter clade, 31% Cytophaga-
Flavobacteriym-Bacteroides (CFB) 
PCR and DGGE analysis of the 
16S rRNA gene 
Gulf of maine 
(US) 
Jasti et al., 2005 
     
Alexandrium spp. 42% Roseobacter clade, 30% Pseudoalteromonas  PCR and DGGE analysis of the 
16S rRNA gene 
Orkney Isles 
(UK) 
Wichels et al., 
2004 
     
Mixed Phytoplankton 67% Roseobacter clade, 33% CFB group PCR and DGGE analysis of the 
16S rRNA gene 
Bay of Fundy 
(US) 
Rooney-Varga et 
al., 2005 
     
Pfiesteria piscicida 50% α-proteobacteria of which 33% were reported to 
belong to the Roseobacter clade 
PCR of the 16S rRNA gene 
Restiction fragment length 
polymorphism analysis (RFLP) 
Laboratory 
culture  
Alavi et al., 2001 
     
Thalassiosira rotula 
and Skeletonema 
costatum 
42% Roseobacter clade, 31% CFB group 
 
 
PCR and DGGE analysis of the 
16S rRNA gene 
Laboratory 
cultures 
Grossart et al., 
2005 
     
Thalassiosira rotula 31% α-proteobacteria (of which >50% Roseobacter 
clade) dominated the free living bacteria in T. rotula 
cultures in contrast 54% at the attached bacteria 
belonged to the CFB group. 
Fluorescent in situ hybridization 
(FISH) 
Laboratory 
culture 
Grossart et al., 
2005 
     
Thalassiosira spp. 38% α-proteobacteria (of which 33% Roseobacter 
clade), 25% CFB group  
PCR and DGGE analysis of the 
16S rRNA gene 
San Diego (US) Riemann et al., 
2000 
     
Eight  different 
Phytoplankton 
Isolated belonging to the Rhodobacter group of which 
more then 50% were members of the Roseobacter clade 
dominated in six out of eight algal cultures with an 
average of 36% of the total culturable density  
16S rRNA analysis of culturable 
bacteria 
Commercial 
hatcheries 
Nicolas et al., 
2004 
     
Oceanic algal blooms 75% α-proteobacteria (of which 35% Roseobacter 
clade), 11% γ-Proteobacteria 
Group-specific 16S rRNA-
targeted oligonucleotides, 16S 
rDNA clone libraries and RFLP 
analysis 
North Atlantic  Gonzalez et al., 
2000 
     
Cymnodinium 
catenatum 
49% α-proteobacteria (of which >55% Roseobacter 
clade), 26% CFB group 
16S rRNA analysis of culturable 
bacteria 
Laboratory 
cultures 
Green et al., 2004 
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It has been suggested that some bacteria are involved in the production of toxin or 
modification of these compounds (Gallacher et al., 1997; Gallacher and Smith 1999), and 
members of the Roseobacter clade may produce sodium channel-blocking (SCB) toxins 
(Vasquez et al., 2001). In contrast some Roseobacter strains degrade or transform algal 
toxins (Smith et al., 2001). Wagner-Dobler and Biebl (2006) suggested that Roseobacter 
strains might have an important role for controlling toxicity, development and duration of 
algal blooms, however the ecology behind their dominance is unknown.  
 
Algae can reach high intracellular concentration of DMSP (Miller and Belas 2004) and 
members of the Roseobacter clade have been linked to the de degradation of DMSP 
especially in the costal regions where DMSP concentration is high (Moran et al., 2003; 
Howard et al., 2006). Furthermore, motility is an important phenotype for the interaction 
between algal and Roseobacter (Miller and Belas 2006) and a DMSP degrading member 
of the Roseobacter clade has chemotaxis towards DMSP (Miller et al., 2004). However, 
only about 50% of tested Roseobacter strains isolated from algal were motile, hence other 
phenotypes may be important in their dominance (Bruhn et al., 2007). Bruhn et al., (2005b) 
suggested that the ability to degrade DMSP could influence the production of TDA, as 
sulphur from DMSP may be used as sulphur source. Even though it has not been possible 
to demonstrate that sulphur from DMSP is used in the formation of TDA (Geng et al., 
2007), it may still be true in the marine environment. 
 
5.1 Antagonistic Interaction among marine bacteria 
 
Bruhn et al., (2007) suggested that the dominance of the Roseobacter clade in the algal 
microbiota may partly be explained by antagonistic interaction between Roseobacter and 
other marine bacteria. 
 
During attachment to particles in the sea interactions among bacteria affect the microbial 
dynamics (Simon et al., 2002). Particle associated isolates showed greater antagonistic 
activity compared to free-living bacteria (Nair and Simidu 1987; Long and Azam 2001), 
which may reflect that particle associated and freely suspended marine bacteria are in 
general different (Giovannoni and Rappe 2000). For members of the Roseobacter clade, 
attached bacteria are 13 times more likely to produce antimicrobial compounds compared 
to their free-living counterparts, in contrast to non-roseobacter marine species (Long and 
Azam 2001). Furthermore, high attachment and production of antibacterial compound 
were correlated for several members of the Roseobacter clade (Bruhn et al., 2005b; Bruhn 
et al., 2007), which may give these bacteria a selective advantage in colonization of algal 
and marine particles. TDA is however, very termolabile also at temperatures found in 
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marine environments, which might question the role of TDA. Following the growth and 
inhibitions zones found in a well diffusion assay for Roseobacter 27-4 and Silicibacter 
TM1040, TDA was detected for about 30 days (Figure 23), indicating a continues 
production within the stationary phase or that the cells somehow stabilise the compound. 
We therefore suggested that TDA have a central role for Roseobacter in antagonistic 
interactions in the marine environment.  
 
 
Figure 23: CFU/ml of Roseobacter 27-4 
in marine broth. Sterile supernatant tested 
in a well diffusion assay with V. 
anguillarum as target organism 
(unpublished results by Bruhn, 
Melchiorsen and Gram). 
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Competitive relationships between antibiotic producing marine bacteria and other non-
producers have been studied in seawater. Producing strains showed a competitive 
advantage against non-producers, as the latter was strongly inhibited (Lemos et al., 1991). 
Production of antibacterial compounds has a role in the colonization of Ulva australis by 
Pseudalteromonas tunicate (Rao et al., 2005). Studies have shown that antagonistic 
attached marine bacteria directly inhibited V. cholerae colonization of particles (Long et al., 
2005). A suggested TDA producing strain of P. gallaeciensis was able to prevent the 
growth of others non-roseobacter bacteria on surfaces, while growing in a biofilm (Rao et 
al., 2005). This strain was also an aggressive colonizer of the alga Ulva australis, since it 
was able to invade and disperse pre-established biofilms of other marine bacteria (Rao et 
al., 2006), even though enhanced resistance to antimicrobial compounds have been found 
by marine bacteria in biofilms (Burmolle et al., 2006). In contrast, Grossart et al., (2003) 
found that bacterial growth rate was the most important parameter controlling the long 
term bacterial population density on agar particles and found no effect of production of 
antibacterial compound.  
 
Not only bacteria-bacteria interactions may be important in the competition in algal 
communities, as marine algal also can produce antibacterial compounds, which may play 
a part in the selection of their associated bacteria (Lustigman and Brown 1991). 
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Furthermore, competition against yeast and fungal may also be important for colonization 
in the marine environments and secondary metabolites produced by P. tunicate were 
affective in competition against fungal and yeast surface communities in the marine 
environment (Franks et al., 2006). TDA produced by Roseobacter stains may also inhibit 
both yeast and fungal (Kintaka et al., 1984; Kawano et al., 1997; Liang 2003). 
 
5.2 Conclusions from chapter 5  
 
Members of the Roseobacter clade are often found in the marine environment and are 
abundant in algal associated communities. Algal associated bacteria may have an 
important role in controlling toxicity, development and duration of algal blooms, hence 
understanding the ecology behind the dominance of Roseobacter may give us an 
understanding of algal blooms. Interactions within the marine environment may play an 
important role in marine ecology and it is suggested that the abilities of Roseobacter to 
attach and produce antibacterial compound gives them a selective advantage in 
colonization of algal, however, this remains to be demonstrated. 
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6 Conclusions and perspectives  
 
The dramatic growth in the aquaculture sector has emphasized the importance of fish 
disease control. Bacterial diseases are important constraints and may be treated with 
antibiotics. However, due to the risk of development and transfer of antibiotic resistance, 
alternative disease control measures must be implemented. The use of probiotics, which 
are live microorganisms that confer a health benefit for the host, may be an alternative to 
antibiotics in some situations. Roseobacter strain 27-4, which has been isolated from a 
turbot larval rearing unit, is a promising probiotic candidate, as it is capable of reducing 
mortality in turbot larvae infected with V. anguillarum.  
 
Roseobacter 27-4 was selected as a putative probiotic candidate due to its strong anti 
Vibrio activity. This inhibitory activity is caused by the antibacterial compound tropodithietic 
acid (TDA), which is produced by several Roseobacter stains. We hypothesize that TDA is 
an important mechanism underlying the probiotic effect of Roseobacter 27-4. Static growth 
conditions enhanced TDA production in several Roseobacter strains. Also, static growth 
conditions favoured the formation of a thick biofilm of rosette shaped aggregates formed at 
the air-liquid interface. The growth in rosettes and biofilm formation appeared to be linked, 
and these growth patterns also appeared connected to the formation of TDA.  
 
Using Roseobacter 27-4 as a probiotic culture requires that it is established under 
conditions that promote TDA production e.g. in biofilm. It is hypothesised in this thesis that 
its colonization of surfaces can enhance its anti-pathogenic effect and hence, create a 
stable longterm beneficial microbiota in aquaculture environments. This may be an 
advantage as probiotic bacteria often have to be added repeatedly to have a disease 
reducing effect. This thesis presents a novel way of quantifying both the probiotic and 
pathogenic bacteria during attachment, by using Real time PCR. Such a method will be 
useful in evaluating the effect of probiotic bacteria during colonization of surfaces. 
 
TDA affects both eukaryotic and prokaryotic cells, but eukaryotes seem less sensitive 
compared to prokaryotes. All bacterial strain tested were sensitive to TDA but non-
Roseobacter strains were in general more sensitive to TDA, as compared to members of 
the Roseobacter clade. Hence production of TDA may give Roseobacter a selective 
advantage during interaction with other bacteria. The mode of action is unknown, but it is 
suggested that TDA react with ion channels and transport proteins. As part of a new 
project we will elucidate the molecular mechanisms by which TDA affects the fish 
pathogens.  
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Members of the Roseobacter clade participate in the sulphur cycle in the marine 
environment, especially the breakdown of the algal compound, dimethylsulfoniopropionate 
(DMSP). Since TDA contains two sulphur atoms one could speculate that DMSP could act 
as substrate for the TDA synthesis. The biosynthesis pathway suggested from transposon 
mutants did not reveal the origin of the sulphur in TDA, but a TDA producing Roseobacter 
strain (Silicibacter TM1040) degrades DMSP. It was, however, not possible to demonstrate 
that DMSP could be used as sulphur source for TDA production. Both cysteine and 
sulphate were suitable substrates for TDA synthesis whereas methionine could not be 
metabolised to TDA. Sulphate is present in the marine environment at concentrations 
sufficient for TDA production and TDA may therefore be produced in the marine 
environment if the required energy is available.   
 
Stabile spontaneously TDA negative mutants are found in several TDA producing 
Roseobacter strains. The biosynthesis pathway showed that the last steps in the formation 
are encoded by genes located on a plasmid, which may explain the loss of TDA production 
as loss of the plasmid. A transfer of this plasmid to other Roseobacter could spread the 
occurrence of TDA producing strains. 
 
Members of the Roseobacter clade are abundant in several marine environments and their 
dominance in algal blooms has been of special interest. It has been suggested that 
members of the Roseobacter clade play an important role in algal blooms, however the 
ecology behind their dominance is not known. Several Roseobacter strains isolated from 
algae produced antibacterial compounds, and some strains also formed rosette shaped 
aggregates, which improved their attachment capability. It is suggested in the present 
thesis that members of the Roseobacter clade may become dominant among algal 
associated bacteria, due to their production of antibacterial compound and high 
attachment capability.  
 
Other marine bacteria than members of the Roseobacter clade produce antibacterial 
compounds. Seen from a biological or ecological point of view, a better understanding of 
these antibacterial compounds may also guide us to an understanding of the balance 
between different marine organisms. Hence an ongoing project will determine the 
mechanisms that govern the interaction between culturable marine bacteria. This will be 
conducted as a part of the Galathea 3 cruise where samples from all around the world will 
be analysed for the presence of bacteria capable of producing antibacterial compounds. 
Antibacterial compounds may be a key to the success of different bacteria in different 
aquatic environments. Also such compounds are likely candidates for development of 
novel antibiotics and other antimicrobial compounds. They have a potential broad use – in 
the clinical sector and animal production as well as in food and biotech processing. 
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